diff --git a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 1/General Microbiology.csv b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 1/General Microbiology.csv
index fbe0088..82ab2f6 100644
--- a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 1/General Microbiology.csv	
+++ b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 1/General Microbiology.csv	
@@ -14,7 +14,7 @@ S_MI_1.1.1.2,Pasteurization,,True,2,2019-08;2009-08,,,
 S_MI_1.2.1.4,Electron Microscope,,True,3,2023-07;2015-02;2011-08,n=MI-apsemm&ed=4&vol=0#9,,
 S_MI_1.2.1.1,Darkground Microscope,- Uses,True,2,2019-08;2012-02,n=MI-apsemm&ed=4&vol=0#7,,
 S_MI_1.2.2.2.4,Fimbriae,,True,2,2023-02;2011-02,n=MI-apsemm&ed=4&vol=0#18,,
-S_MI_1.2.2.2.3,Flagella,- Types;- Bacteria having peritrichate flagella,True,5,2021-09;2015-02;2013-02;2012-02;2009-08,n=MI-apsemm&ed=4&vol=0#17,,
+S_MI_1.2.2.2.3,Flagella,- Types;- Bacteria having peritrichous flagella,True,5,2021-09;2015-02;2013-02;2012-02;2009-08,n=MI-apsemm&ed=4&vol=0#17,,
 S_MI_1.2.2.2.1,Bacterial Capsule,,True,5,2017-08;2014-02;2010-08;2010-02;2008-08,n=MI-apsemm&ed=4&vol=0#17,,
 S_MI_1.2.2.2.2,Slime Layer,,True,1,2020-11,n=MI-apsemm&ed=4&vol=0#17,,
 S_MI_1.2.2.1.1,Bacterial Cell Wall,- Difference between bacterial cell wall of Gram Positive and Gram Negative bacteria,True,1,2016-02,n=MI-apsemm&ed=4&vol=0#14,,
diff --git a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 1/Immunology.csv b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 1/Immunology.csv
index e664ec5..065bf61 100644
--- a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 1/Immunology.csv	
+++ b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 1/Immunology.csv	
@@ -58,8 +58,8 @@ E_MI_1.7,Immunity,"- Types
 - Acquired Immunity",True,1,2005-08,n=MI-apsemm&ed=4&vol=0#119,,
 S_MI_1.10.1.2,Hypersensitivity Type 2,,True,1,2006-02,n=MI-apsemm&ed=4&vol=0#177,,
 S_MI_1.8.5.5,Lymphokines,,True,1,1990-12,n=MI-apsemm&ed=4&vol=0#162,,
-S_MI_1.8.3.4,Immunoflorescence,,True,4,2008-02;2003-08;2000-10;2000-04,n=MI-apsemm&ed=4&vol=0#143,,
-S_MI_1.8.1.3,Hetrophile Antigen,,True,1,1992-04,n=MI-apsemm&ed=4&vol=0#126,,
+S_MI_1.8.3.4,Immunofluorescence,,True,4,2008-02;2003-08;2000-10;2000-04,n=MI-apsemm&ed=4&vol=0#143,,
+S_MI_1.8.1.3,Heterophile Antigen,,True,1,1992-04,n=MI-apsemm&ed=4&vol=0#126,,
 S_MI_1.8.5.2.1,T-Cell Subsets,,True,2,1997-10;1996-10,n=MI-apsemm&ed=4&vol=0#157,,
 S_MI_1.8.6.2,Cell Mediated Immunity,,True,1,1997-04,n=MI-apsemm&ed=4&vol=0#168,,
 S_MI_1.8.6.3,Humoral Immunity,,True,1,1995-11,n=MI-apsemm&ed=4&vol=0#171,,
diff --git a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Bloodstream and Cardiovascular Infections.csv b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Bloodstream and Cardiovascular Infections.csv
index 1b2169d..95b4854 100644
--- a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Bloodstream and Cardiovascular Infections.csv	
+++ b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Bloodstream and Cardiovascular Infections.csv	
@@ -15,7 +15,7 @@ S_MI_2.7.2,Morphology of HIV,,True,3,2023-02;2009-08;2007-08,n=MI-apsemm&ed=4&vo
 S_MI_2.7.3,Laboratory Diagnosis of HIV,,True,4,2022-08;2021-09;2011-08;2004-08,n=MI-apsemm&ed=4&vol=0#288;n=MI-apsemm&ed=3&vol=0#330,,
 S_MI_2.7.4,Opportunistic Infections in HIV,,True,3,2013-08;2011-08;2009-08,n=MI-apsemm&ed=4&vol=0#288;n=MI-apsemm&ed=3&vol=0#330,,
 E_MI_2.7.5,Post Exposure Prophylaxis in HIV,,True,2,2022-02;2017-08,n=MI-apsemm&ed=4&vol=0#238;n=MI-apsemm&ed=4&vol=0#292;n=MI-apsemm&ed=3&vol=0#335,,
-E_MI_2.8.1,Enteric Fever (or) Typhoid Fever,"- Classification of Enterobacteriacea
+E_MI_2.8.1,Enteric Fever (or) Typhoid Fever,"- Classification of Enterobacteriaceae
 - Pathogenesis
 - Clinical Features
 - Laboratory Diagnosis
diff --git a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Central Nervous System Infections.csv b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Central Nervous System Infections.csv
index 01f7e5a..a89eeb6 100644
--- a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Central Nervous System Infections.csv	
+++ b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Central Nervous System Infections.csv	
@@ -26,7 +26,7 @@ E_MI_,Poliomyelitis (or) Polio Virus,"- Enumerate the organisms causing myelitis
 - Prophylaxis",True,8,2023-03;2021-09;2017-02;2012-02;2010-02;2008-02;2002-03;2001-11,n=MI-apsemm&ed=4&vol=0#591;n=MI-apsemm&ed=3&vol=0#709,"A 5 year old male child admitted in ICU with c/o fever, headache and chills. His mother complained that child is not able to stand 5 days after the onset of fever. O/E there is flaccid paralysis of lower limbs and tripod sign is elucidated.  On CSF analysis glucose level and protein level is normal. Microscopic examination of CSF show 25-40 lymphocytes per microlitre and no bacteria seen. Ziehl – Neelsen staining of CSF is negative for Acid Fast bacilli.",
 S_MI_,Toxoplasmosis,"- Clinical Manifestations
 - Lab Diagnosis;- Congenital Toxoplasmosis",True,4,2023-07;2017-08;2014-08;2010-08,n=MI-apsemm&ed=4&vol=0#610;n=MI-apsemm&ed=3&vol=0#731,,
-S_MI_,Neurocysticercosis (or) Cysticercus Cellulosae,"- Clinical Manifestations
+S_MI_,Neurocysticercosis (or) Cysticercus cellulosae,"- Clinical Manifestations
 - Lab Diagnosis",True,10,2023-07;2021-09;2016-02;2014-08;2011-08;2010-08;2005-08;2004-08;2002-03;1998-10;1997-04;1992-04,n=MI-apsemm&ed=4&vol=0#613;n=MI-apsemm&ed=3&vol=0#735,,
 S_MI_,Poliomyelitis (or) Polio Virus,- Prophylaxis;- Lab Diagnosis;- Sabin Vaccine,True,10,2022-08;2019-02;2018-08;2018-02;2015-08;2014-08;2012-08;2009-08;2008-08;2007-02;2005-02;2003-10;1997-10;1996-04;1995-11,n=MI-apsemm&ed=4&vol=0#591;n=MI-apsemm&ed=3&vol=0#709,,
 S_MI_,Subacute Sclerosing Panencephalitis,,True,2,2022-02;2019-02,n=MI-apsemm&ed=4&vol=0#606;n=MI-apsemm&ed=3&vol=0#724,,
@@ -59,5 +59,5 @@ E_MI_,Toxoplasmosis,"- List Parasitic Zoonotic diseases
 - Pathogenesis
 - Lab Diagnosis of Toxoplasmosis",True,1,2006-02,n=MI-apsemm&ed=4&vol=0#610;n=MI-apsemm&ed=3&vol=0#731,,
 S_MI_,Tuberculous Meningitis,,False,1,,n=MI-apsemm&ed=4&vol=0#581;n=MI-apsemm&ed=3&vol=0#699,,
-S_MI_,Listerosis,,False,1,,n=MI-apsemm&ed=4&vol=0#580;n=MI-apsemm&ed=3&vol=0#698,,
+S_MI_,Listeriosis,,False,1,,n=MI-apsemm&ed=4&vol=0#580;n=MI-apsemm&ed=3&vol=0#698,,
 S_MI_,Free-Living Amoebae,,False,6,,n=MI-apsemm&ed=4&vol=0#609;n=MI-apsemm&ed=3&vol=0#727,,
diff --git a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Gastrointestinal Infections.csv b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Gastrointestinal Infections.csv
index fd7e737..6fd3824 100644
--- a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Gastrointestinal Infections.csv	
+++ b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Gastrointestinal Infections.csv	
@@ -12,7 +12,7 @@ E_MI_3.1.3.1,Cholera,"- Enumerate Bacteria causing Diarrhea
 - Prevention;- Morphology
 - Pathogenesis
 - Laboratory diagnosis
-- Treatment",True,8,2022-08;2015-08;2011-02;2010-02;2008-02;2003-10;2001-04;1996-04,n=MI-apsemm&ed=4&vol=0#346;n=MI-apsemm&ed=3&vol=0#410,A 25 year old female admitted with history of **watery diarrhea resembling rice water** of 24 hrs duration along with **copious vomitting**.,
+- Treatment",True,8,2022-08;2015-08;2011-02;2010-02;2008-02;2003-10;2001-04;1996-04,n=MI-apsemm&ed=4&vol=0#346;n=MI-apsemm&ed=3&vol=0#410,A 25 year old female admitted with history of **watery diarrhea resembling rice water** of 24 hrs duration along with **copious vomiting**.,
 S_MI_3.1.3.2,Halophilic Vibrios,- Detail about Halophilic Vibrios;- Non Cholera Vibrios;- Non agglutinating Vibrios,True,5,2013-02;2012-08;2010-02;2001-11;1994-11,n=MI-apsemm&ed=4&vol=0#352;n=MI-apsemm&ed=3&vol=0#417,,
 S_MI_3.1.1,Bacteria Causing Food Poison,- Laboratory diagnosis;- Note on bacterial food poisoning,True,4,2014-08;2010-08;2007-02;2000-10,n=MI-apsemm&ed=4&vol=0#332;n=MI-apsemm&ed=3&vol=0#394,,
 S_MI_3.1.3.1.4,Lab Diagnosis of Cholera,,True,2,2021-09;2018-08,n=MI-apsemm&ed=4&vol=0#349;n=MI-apsemm&ed=3&vol=0#414,,
@@ -80,7 +80,7 @@ S_MI_3.1.1.2,Clostridium botulinum,- Botulism;- Detail about Clostridium botulin
 S_MI_3.1.4.3,Clostridium difficile,,True,2,2018-02;1997-04,n=MI-apsemm&ed=4&vol=0#357;n=MI-apsemm&ed=3&vol=0#422,,
 S_MI_3.1.2.1,General Characteristics of Enterobacteriaceae,,False,1,,n=MI-apsemm&ed=4&vol=0#337;n=MI-apsemm&ed=3&vol=0#400,,
 S_MI_3.1.3.1.5,Prophylaxis and Epidemiology of Cholera,,True,1,2002-03,n=MI-apsemm&ed=4&vol=0#348;n=MI-apsemm&ed=3&vol=0#412,,
-S_MI_3.1.4.1,Campylobactor,,True,2,1993-01;1990-08,n=MI-apsemm&ed=4&vol=0#354;n=MI-apsemm&ed=3&vol=0#419,,
+S_MI_3.1.4.1,Campylobacter,,True,2,1993-01;1990-08,n=MI-apsemm&ed=4&vol=0#354;n=MI-apsemm&ed=3&vol=0#419,,
 S_MI_3.1.1.3,Mycotoxicosis (or) Mycotoxins,,True,7,2023-06;2013-02;2006-08;2004-08;2001-11;1998-11;1995-04,n=MI-apsemm&ed=4&vol=0#335;n=MI-apsemm&ed=3&vol=0#398,,
 S_MI_3.1.7.5.1.2,Larval Forms of Cestodes,,False,1,,n=MI-apsemm&ed=4&vol=0#375;n=MI-apsemm&ed=3&vol=0#447,,
 S_MI_3.1.5.1.2,Hymenolepis nana (or) Dwarf Tapeworm,,False,1,,n=MI-apsemm&ed=4&vol=0#377;n=MI-apsemm&ed=3&vol=0#450,,
@@ -91,6 +91,6 @@ S_MI_3.1.1.1,Listeria monocytogenes,,True,2,2022-02;2011-02,n=MI-apsemm&ed=4&vol
 S_MI_3.1.6.1.1.2,Life Cycle of Entamoeba histolytica,,True,2,2010-08;2000-04,n=MI-apsemm&ed=4&vol=0#362;n=MI-apsemm&ed=3&vol=0#428,,
 E_MI_3.1.7.7.2,Enterobiasis,"- Enumerate Intestinal Parasites
 - Laboratory diagnosis",True,1,1992-04,n=MI-apsemm&ed=4&vol=0#383;n=MI-apsemm&ed=3&vol=0#459,,
-S_MI_3.1.4.4,Bacterioids,,True,1,1995-11,n=MI-apsemm&ed=4&vol=0#327,,
+S_MI_3.1.4.4,Bacterioides,,True,1,1995-11,n=MI-apsemm&ed=4&vol=0#327,,
 S_MI_3.1.7.5.4,Redia and cercaria,,True,2,2002-03;2001-11,n=MI-apsemm&ed=4&vol=0#379,,
 S_MI_3.1.7.5.5,Cyclops,,True,3,2002-03;2001-11;1995-11,n=MI-apsemm&ed=4&vol=0#377,,
diff --git a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Hepatobiliary Infections.csv b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Hepatobiliary Infections.csv
index b5fc62e..f3faad4 100644
--- a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Hepatobiliary Infections.csv	
+++ b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Hepatobiliary Infections.csv	
@@ -17,7 +17,7 @@ E_MI_3.2.1.3,Hepatitis B Virus,"- Morphology
 - Morphology
 - Pathogenesis
 - Lab diagnosis
-- Prophylaxis;- Name the hepatotrophic viruses
+- Prophylaxis;- Name the hepatotropic viruses
 - Pathogenesis
 - Laboratory diagnosis;- Enumerate the viruses transmitted by blood transfusion
 - Hepatitis B virus
@@ -42,7 +42,7 @@ S_MI_3.2.1.3.3,Prevention of Hepatitis B Virus Infection,- Detail about Preventi
 S_MI_3.2.1.3,Hepatitis B Virus,"- Various viral markers
 - Laboratory diagnosis
 - Prophylaxis;- Detail about Hepatitis B Virus",True,2,2022-08;2022-02,n=MI-apsemm&ed=4&vol=0#397;n=MI-apsemm&ed=3&vol=0#478,"A 40-year-old male presented with history of **loss of appetite, malaise and jaundice** of 2 months duration. On examination, there was **icterus, hepatomegaly and tenderness in the right hypochondriac region.** He gave a history of **blood transfusion** in the past. On laboratory examination, he was found to be positive for HBsAg.",
-S_MI_3.2.2.2,Echinococcus granulosus,- Life cycle;- Hydatid disease;- Cyctic Echinococcus;- Dog Tapeworm,True,3,2023-02;2020-02;2009-02,n=MI-apsemm&ed=4&vol=0#410;n=MI-apsemm&ed=3&vol=0#493,,
+S_MI_3.2.2.2,Echinococcus granulosus,- Life cycle;- Hydatid disease;- Cystic Echinococcus;- Dog Tapeworm,True,3,2023-02;2020-02;2009-02,n=MI-apsemm&ed=4&vol=0#410;n=MI-apsemm&ed=3&vol=0#493,,
 E_MI_3.2.2.1,Extra Intestinal Amoebiasis (or) Amoebic Liver Abscess,"- Pathogenesis
 - Clinical features
 - Complication
diff --git a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Respiratory Tract Infections.csv b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Respiratory Tract Infections.csv
index 8da8818..fffa4ae 100644
--- a/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Respiratory Tract Infections.csv	
+++ b/src/Symptum.Data/Subjects/Microbiology/Question Bank/Paper 2/Respiratory Tract Infections.csv	
@@ -14,7 +14,7 @@ S_MI_,Aspergillosis (or) Aspergilloma,"- Pathogenesis
 S_MI_,COVID-19,- Structure of SARS CoV-2,True,2,2023-03;2022-08,n=MI-apsemm&ed=4&vol=0#552;n=MI-apsemm&ed=3&vol=0#662,,
 S_MI_,Pertussis (or) Whooping Cough (or) Bordetella pertussis,- Prophylaxis,True,2,2023-03;2018-02,n=MI-apsemm&ed=4&vol=0#530;n=MI-apsemm&ed=3&vol=0#638,,
 S_MI_,Diphtheria (or) Corynebacterium diphtheriae,"- Pathogenesis
-- Lab Diagnosis;- Elek's Gel Precipitation Test;- Test for Toxin produced by C. diphtheriae",True,9,2023-07;2022-02;2010-08;2009-08;2008-08;2005-08;2003-10;2000-04;1992-04,n=MI-apsemm&ed=4&vol=0#492;n=MI-apsemm&ed=3&vol=0#599,"A 5 year old child had High Grade Fever, Pain in the Throat with Difficulty in Swallowing. On examination the child was Toxic, White Patch was found on the Fauces which bleeds on touch. Immunization status not known.",
+- Lab Diagnosis;- Elek's Gel Precipitation Test;- Test for Toxin produced by C. diphtheriae",True,9,2023-07;2022-02;2010-08;2009-08;2008-08;2005-08;2003-10;2000-04;1992-04,n=MI-apsemm&ed=4&vol=0#492;n=MI-apsemm&ed=3&vol=0#599,"A 5 year old child had High Grade Fever, Pain in the Throat with Difficulty in Swallowing. On examination the child was Toxic, White Patch was found on the throat which bleeds on touch. Immunization status not known.",
 S_MI_,Pulmonary Anthrax,,True,1,2023-07,n=MI-apsemm&ed=4&vol=0#508;n=MI-apsemm&ed=3&vol=0#616,,
 S_MI_,Zygomycosis (or) Mucormycosis,,True,2,2023-02;2017-08,n=MI-apsemm&ed=4&vol=0#564;n=MI-apsemm&ed=3&vol=0#680,,
 S_MI_,Influenza (or) Swine-Flu,"- Specimen Collection
diff --git a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Cell Injury, Cell Death and Adaptations.csv b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Cell Injury, Cell Death and Adaptations.csv
index 0a5a8d6..52d8259 100644
--- a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Cell Injury, Cell Death and Adaptations.csv	
+++ b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Cell Injury, Cell Death and Adaptations.csv	
@@ -21,6 +21,6 @@ S_PA_2.3.1,Fatty Change,- Fatty Liver;- Causes,True,3,2010-02;2005-08;2003-10,n=
 S_PA_2.2.4,Cellular Swelling,,True,1,2006-08,n=PA-rbpbdsa&ed=10&vol=1#37,,
 S_PA_2.7,Cellular Aging,- Role of Sirtuins,True,1,2016-02,n=PA-rbpbdsa&ed=10&vol=1#66,,
 S_PA_2.3.4,Pigments,"- Classification
-- Lipofuschin",True,1,2011-08,n=PA-rbpbdsa&ed=10&vol=1#64,,
+- Lipofuscin",True,1,2011-08,n=PA-rbpbdsa&ed=10&vol=1#64,,
 S_PA_2.6.3,Atrophy,,True,1,2010-02,n=PA-rbpbdsa&ed=10&vol=1#59,,
 S_PA_,Autophagy,,False,1,,n=PA-rbpbdsa&ed=10&vol=1#48,,
diff --git a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Environmental and Nutritional Disorders.csv b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Environmental and Nutritional Disorders.csv
index e257317..8485239 100644
--- a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Environmental and Nutritional Disorders.csv	
+++ b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Environmental and Nutritional Disorders.csv	
@@ -1,17 +1,17 @@
 Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
 S_PA_12.2.1,Protein Energy Malnutrition,,True,2,2018-02;2017-02,n=PA-rbpbdsa&ed=10&vol=1#434,,
-S_PA_12.2.1.2,Kwashiorkar,,True,1,1997-04,n=PA-rbpbdsa&ed=10&vol=1#434,"A 4 year old child has presented with **hyperpigmentation**, **desquamation** and **hyperpigmentation of skin**, **puffiness of face** and **enlarged liver**. **Flag sign positive** in hairs.",
+S_PA_12.2.1.2,Kwashiorkor,,True,1,1997-04,n=PA-rbpbdsa&ed=10&vol=1#434,"A 4 year old child has presented with **hyperpigmentation**, **desquamation** and **hyperpigmentation of skin**, **puffiness of face** and **enlarged liver**. **Flag sign positive** in hairs.",
 S_PA_12.3,Obesity,,True,2,2022-03;2018-08,n=PA-rbpbdsa&ed=10&vol=1#444,,
 E_PA_12.3,Obesity,"- Methods of Assessments
 - Etiopathogenesis
 - Complications",True,1,2014-08,n=PA-rbpbdsa&ed=10&vol=1#444,A 12 year old boy has a history of **eating snacks** and **watching television** with **reduced physical activity** for the past few years. **BMI - 30.5**,
 S_PA_12.4,Vitamin D Deficiency (or) Rickets,,True,7,2023-07;2023-02;2020-02;2018-08;2010-08;2008-08;2005-02,n=PA-rbpbdsa&ed=10&vol=1#440,"A 3 year old male child had **frontal bossing**, **pigeon chest** and **bowing of legs**.",
-S_PA_12.5,Vitamin C Deficiency (or) Scurvy,,True,3,2023-02;2019-08;2015-02,n=PA-rbpbdsa&ed=10&vol=1#442,"A 7 yr old child came with complaints of **bleeding gums**, **hemorrhages** and **healing defects**.",
+S_PA_12.5,Vitamin C Deficiency (or) Scurvy,,True,3,2023-02;2019-08;2015-02,n=PA-rbpbdsa&ed=10&vol=1#442,"A 7 year old child came with complaints of **bleeding gums**, **hemorrhages** and **healing defects**.",
 S_PA_12.2,Nutritional Disorders,,True,1,2022-08,n=PA-rbpbdsa&ed=10&vol=1#433,,
 S_PA_12.6,Vitamin A Deficiency,,True,3,2013-02;2006-08;1997-04,n=PA-rbpbdsa&ed=10&vol=1#437,A 17 year old female who is already diagnosed as a case of **Crohn's disease** came with complaints of **night blindness** and **recurrent infections**.,
-S_PA_12.1.4,Lead poisoning,- Blood and Bone marrow changes,True,2,2016-02;2011-08,n=PA-rbpbdsa&ed=10&vol=1#411,A 12 yr old child came with complaints of **mental retardation**. CBC shows **basophilic stippling**. X-ray show **radiodense lines**.,
+S_PA_12.1.4,Lead poisoning,- Blood and Bone marrow changes,True,2,2016-02;2011-08,n=PA-rbpbdsa&ed=10&vol=1#411,A 12 year old child came with complaints of **mental retardation**. CBC shows **basophilic stippling**. X-ray show **radiodense lines**.,
 S_PA_12.1.5,Radiation Injury,,True,1,2007-08,n=PA-rbpbdsa&ed=10&vol=1#429,,
 S_PA_12.2.2,Anorexia Nervosa and Bulimia,,False,1,,n=PA-rbpbdsa&ed=10&vol=1#435,,
 S_PA_12.1.3,Acute and Chronic effects of Alcohol,,False,1,,n=PA-rbpbdsa&ed=10&vol=1#418,,
 S_PA_12.1.2,Effects of Tobacco,,False,1,,n=PA-rbpbdsa&ed=10&vol=1#415,,
-S_PA_12.1.6,Opiods - Adverse effects,,False,1,,n=PA-rbpbdsa&ed=10&vol=0#424,,
+S_PA_12.1.6,Opioids - Adverse effects,,False,1,,n=PA-rbpbdsa&ed=10&vol=1#424,,
diff --git a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Immunology.csv b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Immunology.csv
index aa2e4b8..82ed521 100644
--- a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Immunology.csv	
+++ b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Immunology.csv	
@@ -16,16 +16,16 @@ E_PA_3.1;3.2,Amyloidosis,"- Pathogenesis
 - Effect On Various Organs",True,10,2022-08;2022-08;2020-11;2020-08;2015-08;2014-08;2013-08;2012-08;2011-02;2010-02;2009-08;2008-02;2005-08;2004-08;2000-04;1995-04,n=PA-rbpbdsa&ed=10&vol=1#259,,
 S_PA_9.2.3,Antibody Mediated (Type 2) Hypersensitivity,,True,5,2018-08;2014-02;2011-02;2002-03;1995-11,n=PA-rbpbdsa&ed=10&vol=1#209,,
 S_PA_9.6.1,Primary Immunodeficiency Syndromes,,True,1,2000-10,n=PA-rbpbdsa&ed=10&vol=1#240,,
-S_PA_9.3.2,Morphology of Transplant Rejection Reactions,,True,4,2022-08;2021-09;2021-02;2000-10,n=PA-rbpbdsa&ed=101&vol=1#235,,
+S_PA_9.3.2,Morphology of Transplant Rejection Reactions,,True,4,2022-08;2021-09;2021-02;2000-10,n=PA-rbpbdsa&ed=10&vol=1#235,,
 S_PA_9.1.1,Natural Killer (NK) cells,,True,1,2001-04,n=PA-rbpbdsa&ed=10&vol=1#192,,
-S_PA_9.3,Major Histocompatibilty Complex (MHC) (or) Human Leukocyte Antigens (HLA),,True,1,2003-10,n=PA-rbpbdsa&ed=10&vol=1#198,,
+S_PA_9.3,Major Histocompatibility Complex (MHC) (or) Human Leukocyte Antigens (HLA),,True,1,2003-10,n=PA-rbpbdsa&ed=10&vol=1#198,,
 S_PA_3.1;3.2,Anti-Nuclear Antibodies,,True,1,2003-10,n=PA-rbpbdsa&ed=10&vol=1#221,,
 S_PA_9.1.4,T-Lymphocyte,,True,1,2004-08,n=PA-rbpbdsa&ed=10&vol=1#194,,
-E_PA_9.2.4,Hypersensitivity Reactions,- Immune complex (Type 3) Hypersensitivity reaction,True,5,2023-02;2022-02;2017-08;2012-02;2009-02,n=PA-rbpbdsa&ed=101&vol=1#204,,
+E_PA_9.2.4,Hypersensitivity Reactions,- Immune complex (Type 3) Hypersensitivity reaction,True,5,2023-02;2022-02;2017-08;2012-02;2009-02,n=PA-rbpbdsa&ed=10&vol=1#204,,
 S_PA_9.2.2,Mast Cells,,True,1,2009-02,n=PA-rbpbdsa&ed=10&vol=1#206,,
 S_PA_9.4,Mechanism of Autoimmune Diseases,,True,3,2023-02;2018-02;2009-08,n=PA-rbpbdsa&ed=10&vol=1#218,,
 S_PA_9.2.2,Anaphylaxis,,True,3,2022-03;2013-02;2010-02,n=PA-rbpbdsa&ed=10&vol=1#208,,
-S_PA_9.2.2,Type 1 (Immediate) Hypersensitivity reaction,,True,4,2020-11;2020-08;2019-02;2010-08,n=PA-rbpbdsa&ed=101&vol=1#205,,
+S_PA_9.2.2,Type 1 (Immediate) Hypersensitivity reaction,,True,4,2020-11;2020-08;2019-02;2010-08,n=PA-rbpbdsa&ed=10&vol=1#205,,
 S_PA_9.5,Renal Changes in SLE,,True,3,2023-07;2014-08;2011-02,n=PA-rbpbdsa&ed=10&vol=1#225,,
 S_PA_9.6.1,Hyper IgM Syndrome,,True,1,2011-02,n=PA-rbpbdsa&ed=10&vol=1#244,,
 S_PA_9.2.4,Arthus reaction,,True,2,2015-02;2012-08,n=PA-rbpbdsa&ed=10&vol=1#212,,
diff --git a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Infancy and Diseases of Childhood.csv b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Infancy and Diseases of Childhood.csv
index 00bf21d..2c9d4a2 100644
--- a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Infancy and Diseases of Childhood.csv	
+++ b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/Infancy and Diseases of Childhood.csv	
@@ -1,9 +1,9 @@
 Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
 S_PA_11.2,Childhood Malignancies,"- Benign Tumors
 - Malignant Tumors",True,3,2019-02;2008-08;1993-11,n=PA-rbpbdsa&ed=10&vol=1#475,,
-S_PA_11.4,Wilms Tumor,- Asked in paper 2 as well,True,8,2023-12;2014-08;2010-08;2008-08;2004-08;2003-10;1999-10;1991-12,n=PA-rbpbdsa&ed=10&vol=1#480,"A 3 yr old child presented with a **unilateral, large abdominal mass** which extend down the pelvis. Histology show **sheets of blue cells**.",
-S_PA_11.5,Homer Wright Pseudo Rosettes (Neuroblastoma Histology),,True,1,2008-04,n=PA-rbpbdsa&ed=10&vol=1#478,A 2 yr old child presented with a **large abdominal mass** and **weight loss**. He has **deep bluish discolouration of skin (Blueberry Muffin Baby)**. Blood - **Elevated levels of VMA (Vanillyl mandellic acid)**.,
-S_PA_11.6,Cystic Fibrosis,- Etiopathogenesis,True,1,2011-02,n=PA-rbpbdsa&ed=10&vol=1#467,A 10 yr old child is hospitalized with **pneumonia** and **difficulty in breathing**. His stools are **large** and contains **undigested particles**. His **sweat chloride levels are elevated**.,
+S_PA_11.4,Wilms Tumor,- Asked in paper 2 as well,True,8,2023-12;2014-08;2010-08;2008-08;2004-08;2003-10;1999-10;1991-12,n=PA-rbpbdsa&ed=10&vol=1#480,"A 3 year old child presented with a **unilateral, large abdominal mass** which extend down the pelvis. Histology show **sheets of blue cells**.",
+S_PA_11.5,Homer Wright Pseudo Rosettes (Neuroblastoma Histology),,True,1,2008-04,n=PA-rbpbdsa&ed=10&vol=1#478,A 2 year old child presented with a **large abdominal mass** and **weight loss**. He has **deep bluish discolouration of skin (Blueberry Muffin Baby)**. Blood - **Elevated levels of VMA (Vanillyl mandellic acid)**.,
+S_PA_11.6,Cystic Fibrosis,- Etiopathogenesis,True,1,2011-02,n=PA-rbpbdsa&ed=10&vol=1#467,A 10 year old child is hospitalized with **pneumonia** and **difficulty in breathing**. His stools are **large** and contains **undigested particles**. His **sweat chloride levels are elevated**.,
 S_PA_11.7,Sudden Infant Death Syndrome (SIDS),,False,1,,n=PA-rbpbdsa&ed=10&vol=1#473,"A 6 month old baby dies **suddenly** with **unexplained** cause even after **proper investigation, autopsy and clinical history**.",
 S_PA_11.8,Phenylketonuria,,False,1,,n=PA-rbpbdsa&ed=10&vol=1#465,A 6 month old baby has **reduced intellectual ability**. His blood sample shows **elevated levels of phenylalanine**.,
 S_PA_11.4,Hemolytic Disease of Newborn (Fetal Hydrops),,True,2,2009-08;1996-04,n=PA-rbpbdsa&ed=10&vol=1#462,,
diff --git a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/White Blood Cells.csv b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/White Blood Cells.csv
index f1fdea4..68782dc 100644
--- a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/White Blood Cells.csv	
+++ b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 1/White Blood Cells.csv	
@@ -1,23 +1,47 @@
-Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
-S_PA_18.1.2,Leukemoid Reactions (or) Leukocytosis,,True,6,2012-08;2008-08;2005-08;2000-04;1999-04;1995-11,n=PA-rbpbdsa&ed=10&vol=1#587;n=PA-rbpbdsa&ed=10&vol=1#102,,
-S_PA_18.2,Leukemia,"- Definition
- FAB classification of leukemia",True,2,2009-08;2008-08,n=PA-rbpbdsa&ed=10&vol=1#590,,
-E_PA_18.2.2.1,Chronic Myeloid Leukemia (CML),"- Diagnosis
- Peripheral smear findings
- Course of disease
- Chromosomal abnormality involved;- Clinical features
- Peripheral smear and bone marrow findings
- Clinical outcome; - Diagnosis
- Molecular basis of this disease
- Morphological features
- Classify myeloproliferative neoplasms",True,4,2023-07;2012-08;2011-08;2009-08,n=PA-rbpbdsa&ed=10&vol=1#622,"A 40 yr old male with H/O chronic fatigue, weight loss since 6 months. O/E pallor, marked splenomegaly+, laboratory report shows Hb 10 gm%, Total leukocyte count 215000/cu.mm Platelets 4 lakhs/cu.mm.",
-E_PA_18.2,Leukemia,"- Classify leukemias
- Describe peripheral blood picture and bone marrow findings in CML;- Classify leukemias
- Describe peripheral blood picture and bone marrow findings in ALL;- Classify leukemias
- Describe blood and bone marrow findings in AML",True,7,2019-08;2010-02;2005-02;1995-11;1993-11;1993-01;1990-12,n=PA-rbpbdsa&ed=10&vol=1#590;n=PA-rbpbdsa&ed=10&vol=1#594;n=PA-rbpbdsa&ed=10&vol=1#597;n=PA-rbpbdsa&ed=10&vol=1#617;n=PA-rbpbdsa&ed=10&vol=1#622,,
-S_PA_19.4.1.1,Reed Sternberg Cell,- Variants;- Types,True,5,2023-02;2022-08;2016-08;2013-02;2010-08,n=PA-rbpbdsa&ed=10&vol=1#612,,
-S_PA_13.1,Leucocytes,- Morphological disorder;- Defects in leucocyte function,True,2,2012-02;1994-11,n=PA-rbpbdsa&ed=10&vol=1#241,,
-S_PA_18.2.1.1,Acute Myeloid Leukemia (AML),- Classification;- WHO Classification;- Morphological classification,True,3,2022-08;2013-08;1996-04,n=PA-rbpbdsa&ed=10&vol=1#617,,
-S_PA_18.2.1,Acute Leukemia,- Classification;- Cytochemistry;- FAB classification,True,4,2020-02;2011-02;2000-10;1997-04,n=PA-rbpbdsa&ed=10&vol=1#594;n=PA-rbpbdsa&ed=10&vol=1#617,,
-S_PA_18.2.2.1,Chronic Myeloid Leukemia (CML),"- Blood picture of CML;- Mutations in CML;- Diagnosis
- Diagram of peripheral smear
- Common genetic abnormality",True,5,2022-03;2020-11;2020-02;2016-08;1998-04,n=PA-rbpbdsa&ed=10&vol=1#622,"A 30 year old male presented with massive splenomegaly, His total leukocyte count was 235,000 cells/cu.mm with more neutrophil precursors. Platelet count was 1,80,000 cells/cu.mm.",
-S_PA_19.4.1.2,Nodular Sclerosis,,True,1,2006-02,n=PA-rbpbdsa&ed=10&vol=1#612,,
-S_PA_18.1.1,Agranulocytosis,"- Diagnosis
- Pathogenesis;- Definition",True,4,2022-08;2016-02;2013-02;1998-04,n=PA-rbpbdsa&ed=10&vol=1#586,A 20 year old male following antibiotic intake had total leukocyte count of 1200 cells/cu.mm and absolute neutrophil count of 120 cells.,
-E_PA_18.2.1,Acute Myeloid Leukemia (AML),"- Etiopathogenesis
- Clinical features
- Lab investigations",True,1,2006-08,n=PA-rbpbdsa&ed=10&vol=1#617,,
-E_PA_18.2.2,Chronic Myeloproliferative Disorders,,True,1,2007-08,n=PA-rbpbdsa&ed=10&vol=1#621,,
-S_PA_13.1.1,Myelodysplastic Syndrome,,True,2,2016-02;2007-08,n=PA-rbpbdsa&ed=10&vol=1#620,,
-S_PA_19.4.1,Hodgkin's lymphoma,- Classification of Hodgkin's lymphoma;- Morphology and types;- Pathological types;- Subtypes of Hodgkin's lymphoma;- Molecular pathogenesis and Morphology;- AETCOM: Empathising and Supporting your friend (18/M) with Hodgkin's lymphoma,True,6,2022-08;2022-03;2021-09;2015-02;2013-08;2007-08,n=PA-rbpbdsa&ed=10&vol=1#611,,
-S_PA_20.1.1,Multiple Myeloma,- Blood and bone marrow picture;-Morphology,True,7,2023-07;2023-02;2022-03;2022-02;2019-02;2013-08;2011-08,n=PA-rbpbdsa&ed=10&vol=1#607,A 70 year old woman admitted with worsening anemia and pathological fracture of the Humerus had an ESR of 120 mm/hr. Her peripheral smear showed increased Rouleaux formation. X-ray of skull showed multiple punched out osteolytic lesions.,
-E_PA_20.1.1,Multiple Myeloma,"- Diagnosis
- Etiopathogenesis
- Bone marrow changes
- Lab investigations
- Complications;- Diagnosis
- Molecular pathogenesis
- Morphology
- Clinical features",True,2,2012-02;2011-02,n=PA-rbpbdsa&ed=10&vol=1#607,"A 60 year old male presented with normocytic normochromic anaemia, pathological fracture of femur and proteinuria. X-ray skull revealed punched out lesions in the calvarium and peripheral smear studied show rouleaux formation.;A 60 year old male presented with low back ache. He had multiple lytic lesions of bones on skeletal survey. Serum electrophoresis and bone narrow was done to establish diagnosis.",
-S_PA_13.1.2,Primary Myelofibrosis,,True,2,2015-08;2012-02,n=PA-rbpbdsa&ed=10&vol=1#626,,
-S_PA_13.1.1,Pseudo Pelger-Huët Anomaly,,True,1,2012-02,n=PA-rbpbdsa&ed=10&vol=1#620,,
-S_PA_20.1.1.1,Russell Bodies,,True,2,2017-02;2014-08,n=PA-rbpbdsa&ed=10&vol=1#608,,
-S_PA_,Leucocyte Alkaline Phosphatase,,True,1,2014-08,,,
-S_PA_13.1.3,Langerhann Cell Histiocytosis,,True,1,2015-08,n=PA-rbpbdsa&ed=10&vol=1#627,,
+Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
+S_PA_18.1.2,Leukemoid Reactions (or) Leukocytosis,,True,6,2012-08;2008-08;2005-08;2000-04;1999-04;1995-11,n=PA-rbpbdsa&ed=10&vol=1#587;n=PA-rbpbdsa&ed=10&vol=1#102,,
+S_PA_18.2,Leukemia,"- Definition
+- FAB classification of leukemia",True,2,2009-08;2008-08,n=PA-rbpbdsa&ed=10&vol=1#590,,
+E_PA_18.2.2.1,Chronic Myeloid Leukemia (CML),"- Diagnosis
+- Peripheral smear findings
+- Course of disease
+- Chromosomal abnormality involved;- Clinical features
+- Peripheral smear and bone marrow findings
+- Clinical outcome; - Diagnosis
+- Molecular basis of this disease
+- Morphological features
+- Classify myeloproliferative neoplasms",True,4,2023-07;2012-08;2011-08;2009-08,n=PA-rbpbdsa&ed=10&vol=1#622,"A 40 year old male with H/O chronic fatigue, weight loss since 6 months. O/E pallor, marked splenomegaly+, laboratory report shows Hb 10 gm%, Total leukocyte count 215000/cu.mm Platelets 4 lakhs/cu.mm.",
+E_PA_18.2,Leukemia,"- Classify leukemias
+- Describe peripheral blood picture and bone marrow findings in CML;- Classify leukemias
+- Describe peripheral blood picture and bone marrow findings in ALL;- Classify leukemias
+- Describe blood and bone marrow findings in AML",True,7,2019-08;2010-02;2005-02;1995-11;1993-11;1993-01;1990-12,n=PA-rbpbdsa&ed=10&vol=1#590;n=PA-rbpbdsa&ed=10&vol=1#594;n=PA-rbpbdsa&ed=10&vol=1#597;n=PA-rbpbdsa&ed=10&vol=1#617;n=PA-rbpbdsa&ed=10&vol=1#622,,
+S_PA_19.4.1.1,Reed Sternberg Cell,- Variants;- Types,True,5,2023-02;2022-08;2016-08;2013-02;2010-08,n=PA-rbpbdsa&ed=10&vol=1#612,,
+S_PA_13.1,Leucocytes,- Morphological disorder;- Defects in leucocyte function,True,2,2012-02;1994-11,n=PA-rbpbdsa&ed=10&vol=1#241,,
+S_PA_18.2.1.1,Acute Myeloid Leukemia (AML),- Classification;- WHO Classification;- Morphological classification,True,3,2022-08;2013-08;1996-04,n=PA-rbpbdsa&ed=10&vol=1#617,,
+S_PA_18.2.1,Acute Leukemia,- Classification;- Cytochemistry;- FAB classification,True,4,2020-02;2011-02;2000-10;1997-04,n=PA-rbpbdsa&ed=10&vol=1#594;n=PA-rbpbdsa&ed=10&vol=1#617,,
+S_PA_18.2.2.1,Chronic Myeloid Leukemia (CML),"- Blood picture of CML;- Mutations in CML;- Diagnosis
+- Diagram of peripheral smear
+- Common genetic abnormality",True,5,2022-03;2020-11;2020-02;2016-08;1998-04,n=PA-rbpbdsa&ed=10&vol=1#622,"A 30 year old male presented with massive splenomegaly, His total leukocyte count was 235,000 cells/cu.mm with more neutrophil precursors. Platelet count was 1,80,000 cells/cu.mm.",
+S_PA_19.4.1.2,Nodular Sclerosis,,True,1,2006-02,n=PA-rbpbdsa&ed=10&vol=1#612,,
+S_PA_18.1.1,Agranulocytosis,"- Diagnosis
+- Pathogenesis;- Definition",True,4,2022-08;2016-02;2013-02;1998-04,n=PA-rbpbdsa&ed=10&vol=1#586,A 20 year old male following antibiotic intake had total leukocyte count of 1200 cells/cu.mm and absolute neutrophil count of 120 cells.,
+E_PA_18.2.1,Acute Myeloid Leukemia (AML),"- Etiopathogenesis
+- Clinical features
+- Lab investigations",True,1,2006-08,n=PA-rbpbdsa&ed=10&vol=1#617,,
+E_PA_18.2.2,Chronic Myeloproliferative Disorders,,True,1,2007-08,n=PA-rbpbdsa&ed=10&vol=1#621,,
+S_PA_13.1.1,Myelodysplastic Syndrome,,True,2,2016-02;2007-08,n=PA-rbpbdsa&ed=10&vol=1#620,,
+S_PA_19.4.1,Hodgkin's lymphoma,- Classification of Hodgkin's lymphoma;- Morphology and types;- Pathological types;- Subtypes of Hodgkin's lymphoma;- Molecular pathogenesis and Morphology;- AETCOM: Empathising and Supporting your friend (18/M) with Hodgkin's lymphoma,True,6,2022-08;2022-03;2021-09;2015-02;2013-08;2007-08,n=PA-rbpbdsa&ed=10&vol=1#611,,
+S_PA_20.1.1,Multiple Myeloma,- Blood and bone marrow picture;-Morphology,True,7,2023-07;2023-02;2022-03;2022-02;2019-02;2013-08;2011-08,n=PA-rbpbdsa&ed=10&vol=1#607,A 70 year old woman admitted with worsening anemia and pathological fracture of the Humerus had an ESR of 120 mm/hr. Her peripheral smear showed increased Rouleaux formation. X-ray of skull showed multiple punched out osteolytic lesions.,
+E_PA_20.1.1,Multiple Myeloma,"- Diagnosis
+- Etiopathogenesis
+- Bone marrow changes
+- Lab investigations
+- Complications;- Diagnosis
+- Molecular pathogenesis
+- Morphology
+- Clinical features",True,2,2012-02;2011-02,n=PA-rbpbdsa&ed=10&vol=1#607,"A 60 year old male presented with normocytic normochromic anaemia, pathological fracture of femur and proteinuria. X-ray skull revealed punched out lesions in the calvarium and peripheral smear studied show rouleaux formation.;A 60 year old male presented with low back ache. He had multiple lytic lesions of bones on skeletal survey. Serum electrophoresis and bone narrow was done to establish diagnosis.",
+S_PA_13.1.2,Primary Myelofibrosis,,True,2,2015-08;2012-02,n=PA-rbpbdsa&ed=10&vol=1#626,,
+S_PA_13.1.1,Pseudo Pelger-Huët Anomaly,,True,1,2012-02,n=PA-rbpbdsa&ed=10&vol=1#620,,
+S_PA_20.1.1.1,Russell Bodies,,True,2,2017-02;2014-08,n=PA-rbpbdsa&ed=10&vol=1#608,,
+S_PA_,Leucocyte Alkaline Phosphatase,,True,1,2014-08,,,
+S_PA_13.1.3,Langerhans Cell Histiocytosis,,True,1,2015-08,n=PA-rbpbdsa&ed=10&vol=1#627,,
diff --git a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Endocrinology.csv b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Endocrinology.csv
index 9128024..7a36fca 100644
--- a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Endocrinology.csv	
+++ b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Endocrinology.csv	
@@ -7,7 +7,7 @@ E_PA_32.3.1,Diabetes Mellitus,"- Etiopathogenesis
 - Complications ",True,2,2015-02;2008-08,n=PA-rbpbdsa&ed=10&vol=2#1097,,
 S_PA_32.1.1,Cretinism,,True,1,2008-08,n=PA-rbpbdsa&ed=10&vol=2#1078,,
 S_PA_32.4.3,Pheochromocytoma,,True,7,2018-08;2013-08;2011-08;2010-02;2009-08;2009-02;2005-02,n=PA-rbpbdsa&ed=10&vol=2#1127,,
-S_PA_32.1.6.1,Papillary Carcinoma Thyroid,,True,6,2020-02;2012-02;2011-02;2010-08;2010-02;2005-08,n=PA-rbpbdsa&ed=10&vol=2#1088,,
+S_PA_32.1.6.1,Papillary Carcinoma of Thyroid,,True,6,2020-02;2012-02;2011-02;2010-08;2010-02;2005-08,n=PA-rbpbdsa&ed=10&vol=2#1088,,
 S_PA_32.3.1.1.1;32.3.1.2;32.3.1.3,Diabetes Mellitus,"- Pathogenesis
 - Complications;- Lab Diagnosis",True,3,2017-02;2010-08;1996-04,n=PA-rbpbdsa&ed=10&vol=2#1101,,
 S_PA_32.1.2.1;32.1.2.2;32.1.2.3,Thyroiditis,"- Hashimoto's Thyroiditis
@@ -18,9 +18,9 @@ S_PA_32.1.2.1,Hashimoto's Thyroiditis,"- Pathogenesis
 - Morphology
 - Clinical Features",True,10,2017-08;2014-02;2012-08;2009-08;2008-02;2003-10;2001-04;2000-10;1999-04;1997-04;1994-11;1993-11;1991-01,n=PA-rbpbdsa&ed=10&vol=2#1078,,
 S_PA_32.3.2.2,Diabetic Microangiopathy,,True,1,2015-08,n=PA-rbpbdsa&ed=10&vol=2#1109,,
-S_PA_32.1.3,Graves Disease,,True,3,2018-02;2016-02;2006-02,n=PA-rbpbdsa&ed=10&vol=2#1081,"A 30 year old female presented with Diarrhea, Weight loss, Protruding eye balls and Thyromegaly",
+S_PA_32.1.3,Graves' Disease,,True,3,2018-02;2016-02;2006-02,n=PA-rbpbdsa&ed=10&vol=2#1081,"A 30 year old female presented with Diarrhea, Weight loss, Protruding eye balls and Thyromegaly",
 E_PA_32.4.1,Cushing Syndrome,,True,1,2019-02,n=PA-rbpbdsa&ed=10&vol=2#1115,,
-E_PA_32.1.6.1,Papillary Carcinome Thyroid,"- Classify Thyroid Neoplasms
+E_PA_32.1.6.1,Papillary Carcinoma of Thyroid,"- Classify Thyroid Neoplasms
 - Pathogenesis of Malignant Thyroid Neoplasm
 - Morphology of Papillary Carcinoma of Thyroid ",True,3,2022-08;2021-09;2011-08,n=PA-rbpbdsa&ed=10&vol=2#1086,,
 S_PA_32.1.7,FNAC in Thyroid Lesions,"- FNAC Importance
diff --git a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Female Genital Tract.csv b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Female Genital Tract.csv
index 61dcbef..215e90c 100644
--- a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Female Genital Tract.csv	
+++ b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Female Genital Tract.csv	
@@ -1,29 +1,30 @@
-Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
-E_PA_30.1,Carcinoma of Cervix,"- Probable diagnosis
-- Etiopathogenesis
-- Clinical features
-- Investigation done to confirm diagnosis;- Probable diagnosis
-- Etiopathogenesis
-- Clinical features",True,2,2020-02;2008-02,n=PA-rbpbdsa&ed=10&vol=2#998,"A 60 year old female, postmenopausal, anorexic, cachectic women has ulcerated & friable cervix that bleeds on touch. Features accompanied by foul smelling vaginal discharge.",
-S_PA_30.1,Carcinoma of Cervix,- Etiology,True,3,2023-07;2011-02;2009-08,n=PA-rbpbdsa&ed=10&vol=2#996,,
-S_PA_30.1,Role of Pap Smear in Cancer Screening,,True,1,2022-03,n=PA-rbpbdsa&ed=10&vol=2#1000,,
-S_PA_30.4.3,Teratoma of Ovary,"- What is Teratoma?
-- Common sites involved;- Classification
-- Pathomorphology of Teratoma of Ovary;- Gross features of Mature Cystic Teratoma;- Morphology
-- Belongs to which group of Ovarian lesions
-- Enumerate other lesions",True,4,2023-02;2022-08;2020-11;2012-02,n=PA-rbpbdsa&ed=10&vol=2#1023,"A 15 year old female, presented with unilateral **Ovarian Mass**. Gross examination revealed **hair** in it. ",
-S_PA_,Krukenberg Tumor,,True,2,2023-07;2013-02,n=PA-rbpbdsa&ed=10&vol=1#1028,,
-S_PA_30.9,Endometrial Hyperplasia,,True,1,2023-02,n=PA-rbpbdsa&ed=10&vol=2#1006,,
-S_PA_30.4.3.3,Struma Ovarii,,True,2,2022-08;2013-08,n=PA-rbpbdsa&ed=10&vol=1#1024,,
-S_PA_30.5,Hydatidiform Mole,- Sites of Ectopic Gestation,True,4,2022-02;2014-08;2014-02;2010-02,n=PA-rbpbdsa&ed=10&vol=1#1033,,
-S_PA_30.4.3,Germ Cell Tumours of Ovary,,True,2,2020-02;2016-02,n=PA-rbpbdsa&ed=10&vol=1#1023,,
-S_PA_30.4.3.4,Dysgerminoma,- Microscopic features,True,3,2019-08;2011-02;2010-02,n=PA-rbpbdsa&ed=10&vol=1#1024,,
-S_PA_30.1,Cervical Intraepithelial Neoplasia,,True,4,2018-02;2015-02;2014-02;2010-02,n=PA-rbpbdsa&ed=10&vol=2#997,,
-S_PA_30.7,Endometrosis,"- Definition
-- 4 Sites involved",True,5,2021-09;2018-08;2017-02;2013-08;2009-08,n=PA-rbpbdsa&ed=10&vol=1#1004,,
-S_PA_30.4.3.2,Dermoid Cyst (or) Mature (Benign) Teratoma of Ovary,,True,1,2011-08,n=PA-rbpbdsa&ed=10&vol=1#1023,,
-S_PA_30.2,Malignant Tumors of Endometrium,- Types of Endometrial tumors,True,1,2011-08,n=PA-rbpbdsa&ed=10&vol=1#1008,,
-S_PA_30.4.2,Sex Cord Stromal Tumors of Ovary,,True,1,2015-08,n=PA-rbpbdsa&ed=10&vol=1#1026,,
-E_PA_30.4;30.4.3;30.4.1.1,Ovarian Neoplasms,"- Classification
- Note on Germ Cell Tumors;- Classification
-- Molecular Pathogenesis & Morphology of Serous tumors",True,4,2023-12;2017-08;2013-08;2012-02,n=PA-rbpbdsa&ed=10&vol=2#1016,,
-S_PA_30.4.1,Ovarian Tumors,- Surface epithelial Tumors,True,3,2017-08;2016-02;2010-07,n=PA-rbpbdsa&ed=10&vol=2#1017,,
+Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
+E_PA_30.1,Carcinoma of Cervix,"- Probable diagnosis
+- Etiopathogenesis
+- Clinical features
+- Investigation done to confirm diagnosis;- Probable diagnosis
+- Etiopathogenesis
+- Clinical features",True,2,2020-02;2008-02,n=PA-rbpbdsa&ed=10&vol=2#998,"A 60 year old female, postmenopausal, anorexic, cachectic women has ulcerated & friable cervix that bleeds on touch. Features accompanied by foul smelling vaginal discharge.",
+S_PA_30.1,Carcinoma of Cervix,- Etiology,True,3,2023-07;2011-02;2009-08,n=PA-rbpbdsa&ed=10&vol=2#996,,
+S_PA_30.1,Role of Pap Smear in Cancer Screening,,True,1,2022-03,n=PA-rbpbdsa&ed=10&vol=2#1000,,
+S_PA_30.4.3,Teratoma of Ovary,"- What is Teratoma?
+- Common sites involved;- Classification
+- Pathomorphology of Teratoma of Ovary;- Gross features of Mature Cystic Teratoma;- Morphology
+- Belongs to which group of Ovarian lesions
+- Enumerate other lesions",True,4,2023-02;2022-08;2020-11;2012-02,n=PA-rbpbdsa&ed=10&vol=2#1023,"A 15 year old female, presented with unilateral **Ovarian Mass**. Gross examination revealed **hair** in it. ",
+S_PA_,Krukenberg Tumor,,True,2,2023-07;2013-02,n=PA-rbpbdsa&ed=10&vol=1#1028,,
+S_PA_30.9,Endometrial Hyperplasia,,True,1,2023-02,n=PA-rbpbdsa&ed=10&vol=2#1006,,
+S_PA_30.4.3.3,Struma Ovarii,,True,2,2022-08;2013-08,n=PA-rbpbdsa&ed=10&vol=1#1024,,
+S_PA_30.5,Hydatidiform Mole,- Sites of Ectopic Gestation,True,4,2022-02;2014-08;2014-02;2010-02,n=PA-rbpbdsa&ed=10&vol=1#1033,,
+S_PA_30.4.3,Germ Cell Tumours of Ovary,,True,2,2020-02;2016-02,n=PA-rbpbdsa&ed=10&vol=1#1023,,
+S_PA_30.4.3.4,Dysgerminoma,- Microscopic features,True,3,2019-08;2011-02;2010-02,n=PA-rbpbdsa&ed=10&vol=1#1024,,
+S_PA_30.1,Cervical Intraepithelial Neoplasia,,True,4,2018-02;2015-02;2014-02;2010-02,n=PA-rbpbdsa&ed=10&vol=2#997,,
+S_PA_30.7,Endometriosis,"- Definition
+- 4 Sites involved",True,5,2021-09;2018-08;2017-02;2013-08;2009-08,n=PA-rbpbdsa&ed=10&vol=1#1004,,
+S_PA_30.4.3.2,Dermoid Cyst (or) Mature (Benign) Teratoma of Ovary,,True,1,2011-08,n=PA-rbpbdsa&ed=10&vol=1#1023,,
+S_PA_30.2,Malignant Tumors of Endometrium,- Types of Endometrial tumors,True,1,2011-08,n=PA-rbpbdsa&ed=10&vol=1#1008,,
+S_PA_30.4.2,Sex Cord Stromal Tumors of Ovary,,True,1,2015-08,n=PA-rbpbdsa&ed=10&vol=1#1026,,
+E_PA_30.4;30.4.3;30.4.1.1,Ovarian Neoplasms,"- Classification
+- Note on Germ Cell Tumors;- Classification
+- Molecular Pathogenesis & Morphology of Serous tumors",True,4,2023-12;2017-08;2013-08;2012-02,n=PA-rbpbdsa&ed=10&vol=2#1016,,
+S_PA_30.4.1,Ovarian Tumors,- Surface epithelial Tumors,True,3,2017-08;2016-02;2010-07,n=PA-rbpbdsa&ed=10&vol=2#1017,,
diff --git a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Gastrointestinal System.csv b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Gastrointestinal System.csv
index 7e73d90..82ae44b 100644
--- a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Gastrointestinal System.csv	
+++ b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Gastrointestinal System.csv	
@@ -1,6 +1,6 @@
 Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
 S_PA_,Gastric Adenocarcinoma (or) Gastric Cancer,"- Morphological Classification
-- Microscopic Finidings
+- Microscopic Findings
 - Linitis Plastica;- Pathogenesis
 - Morphology",True,6,2022-03;2019-08;2016-02;2011-08;2006-02;1997-04,n=PA-rbpbdsa&ed=10&vol=2#774,"A **55 year old** male, with C/O **weight loss** and **dyspepsia.** Endoscopy revealed an **ulcerative lesion in antrum.**",
 S_PA_,Crohn's Disease (or) Regional Ileitis,"- Etiopathogenesis
diff --git a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Heart.csv b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Heart.csv
index 08bc0b3..28741bc 100644
--- a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Heart.csv	
+++ b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Heart.csv	
@@ -26,4 +26,4 @@ S_PA_27.5,Complications of MI,,True,1,2014-02,n=PA-rbpbdsa&ed=10&vol=1#551,,
 S_PA_27.4,Rheumatic Fever,,True,4,2016-08;2003-10;1999-04;1992-04,n=PA-rbpbdsa&ed=10&vol=1#560,,
 S_PA_27.6,Vegetations of Heart,,True,1,2012-02,n=PA-rbpbdsa&ed=10&vol=1#564,,
 S_PA_27.5,Lab Investigations for MI,,True,3,2012-02;2006-02;1993-11,n=PA-rbpbdsa&ed=10&vol=1#550,,
-S_PA_27.15,Tetrology of Fallot,,True,1,2000-04,n=PA-rbpbdsa&ed=10&vol=1#538,,
+S_PA_27.15,Tetralogy of Fallot,,True,1,2000-04,n=PA-rbpbdsa&ed=10&vol=1#538,,
diff --git a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Kidney.csv b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Kidney.csv
index 5546850..a13f94f 100644
--- a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Kidney.csv	
+++ b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Kidney.csv	
@@ -2,7 +2,7 @@ Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations
 S_PA_28.14,Nephroma (or) Renal Cell Carcinoma,- Morphology;- Clear Cell Carcinoma of Kidney,True,4,2012-02;2008-08;2004-08;1991-01,n=PA-rbpbdsa&ed=10&vol=2#948,,
 S_PA_28.12,Contracted Granular Kidney,,True,3,2015-02;2001-04;1993-11,n=PA-rbpbdsa&ed=10&vol=2#941,,
 S_PA_28.5.2,Acute Proliferative Glomerulonephritis,- Urinary Findings,True,1,1994-11,n=PA-rbpbdsa&ed=10&vol=2#906,,
-S_PA_28.5.2.1,Crescentric Glomerulonephritis,- Goodpasture Syndrome,True,5,2014-08;2013-08;2009-02;2008-02;1994-04,n=PA-rbpbdsa&ed=10&vol=2#909,,
+S_PA_28.5.2.1,Crescentic Glomerulonephritis,- Goodpasture Syndrome,True,5,2014-08;2013-08;2009-02;2008-02;1994-04,n=PA-rbpbdsa&ed=10&vol=2#909,,
 E_PA_28.5.1.1,Acute Proliferative Nephritis,"- Etiopathogenesis
 - Pathology
 - Morphology
diff --git a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Liver, Gall bladder and Pancreas.csv b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Liver, Gall bladder and Pancreas.csv
index 018d647..7551a7e 100644
--- a/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Liver, Gall bladder and Pancreas.csv	
+++ b/src/Symptum.Data/Subjects/Pathology/Question Bank/Paper 2/Liver, Gall bladder and Pancreas.csv	
@@ -29,7 +29,7 @@ S_PA_25.7,Metabolic Cirrhosis,,True,1,2011-02,n=PA-rbpbdsa&ed=10&vol=2#848,,
 S_PA_25.10.2,Benign Neoplasms of Liver,,True,1,2011-08,n=PA-rbpbdsa&ed=10&vol=2#866,,
 S_PA_25.15.1,Acute Pancreatitis,"- Morphology;- Causes;- Etiological Factors;- Aetiology
 - Pathology",True,5,2020-11;2017-08;2013-08;2012-02;2003-10,n=PA-rbpbdsa&ed=10&vol=2#882,,
-S_PA_25.3.6.4,Chronic Hepatitis,- Chronic Active Viral Hepatitis,True,8,2012-08;2005-02;2004-08;2003-10;2002-03;2001-11;1999-04;1996-04,n=PA-hartop&ed=7&vol=1#596,,
+S_PA_25.3.6.4,Chronic Hepatitis,- Chronic Active Viral Hepatitis,True,8,2012-08;2005-02;2004-08;2003-10;2002-03;2001-11;1999-04;1996-04,n=PA-rbpbdsa&ed=10&vol=2#837,,
 E_PA_25.10,Tumors of Liver,,True,1,2013-02,n=PA-rbpbdsa&ed=10&vol=2#865,,
 S_PA_25.4.1.4,Laennec Cirrhosis,- Morphology,True,1,2013-02,n=PA-rbpbdsa&ed=10&vol=2#843,,
 S_PA_25.8.1,Hereditary Unconjugated Hyperbilirubinemia,,True,1,2013-08,n=PA-rbpbdsa&ed=10&vol=2#853;n=PA-ramd&ed=2&vol=1#526,,
@@ -51,7 +51,7 @@ E_PA_25.4.1,Alcoholic Liver Disease,"- Investigation
 - Complications",True,1,2022-03,n=PA-rbpbdsa&ed=10&vol=2#842,A 50 year male alcoholic presented with jaundice.,
 S_PA_25.13.1,Acute Cholecystitis,,True,1,2022-08,n=PA-rbpbdsa&ed=10&vol=2#875,A 40 year old obese female with complaints of severe abdominal pain radiating to the right shoulder. Ultrasound was done and she was advised Cholecystectomy by the surgeon.,
 S_PA_25.5.3.2,Ascitic Fluid Cytology,,True,1,2023-02,n=PA-rbpbdsa&ed=10&vol=2#829;n=PA-prtpat&ed=3&vol=1#157,,
-E_PA_25.10.3,Hepatocellular Carcinoma,,True,1,2007-08,n=PA-rbpbdsa&ed=10&vol=2#868,"52 year male was admitted with persistent abdominal pain, gastric distention and vomiting. He had history of loss of appetite, loss of weight and haemetemesis. What is the most probable diagnosis?",
+E_PA_25.10.3,Hepatocellular Carcinoma,,True,1,2007-08,n=PA-rbpbdsa&ed=10&vol=2#868,"52 year male was admitted with persistent abdominal pain, gastric distention and vomiting. He had history of loss of appetite, loss of weight and haematemesis. What is the most probable diagnosis?",
 S_PA_25.4,Fatty Liver,- Pathology,True,2,2005-08;1991-12,n=PA-rbpbdsa&ed=10&vol=2#842,,
 S_PA_25.2,Hepatic Failure,,False,1,,n=PA-rbpbdsa&ed=10&vol=2#826,,
 S_PA_25.5,Portal Hypertension,,False,1,,n=PA-rbpbdsa&ed=10&vol=2#828,,
diff --git a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Autacoids.csv b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Autacoids.csv
index 67ed7d1..c6ce817 100644
--- a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Autacoids.csv	
+++ b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Autacoids.csv	
@@ -5,18 +5,18 @@ E_PH_1.16.4.1.1,Salicylates,"- Mechanism of Action
 - Adverse Effects
 - Classification of NSAIDS",True,5,2023-02;2015-02;2008-08;2008-02;2001-11,n=PH-kdtemp&ed=8&vol=0#212;n=PH-tarav&ed=4&vol=0#241,,
 S_PH_1.16.3.1.1,Therapeutic Uses of Prostaglandins,,True,7,2022-08;2017-02;2014-02;2011-08;2011-02;2010-08;2008-08,n=PH-kdtemp&ed=8&vol=0#205;n=PH-tarav&ed=4&vol=0#238,,
-S_PH_1.16.2.2.1,Pharmacotherapy of Migrane,- Selective Serotonin (5-HT) 1B/1D agonist;- Sumatriptan,True,5,2022-08;2019-02;2015-02;2012-08;2010-08,n=PH-kdtemp&ed=8&vol=0#192;n=PH-tarav&ed=4&vol=0#235,,
+S_PH_1.16.2.2.1,Pharmacotherapy of Migraine,- Selective Serotonin (5-HT) 1B/1D agonist;- Sumatriptan,True,5,2022-08;2019-02;2015-02;2012-08;2010-08,n=PH-kdtemp&ed=8&vol=0#192;n=PH-tarav&ed=4&vol=0#235,,
 S_PH_1.16.5.2;1.16.5.2.1,Drug therapy of Chronic Gout,- Uricosuric Agents;- Probenecid,True,7,2023-07;2023-02;2022-02;2015-02;2011-08;2010-08;2008-02,n=PH-kdtemp&ed=8&vol=0#232;n=PH-tarav&ed=4&vol=0#250,,
-S_PH_1.16.1.1.1.3,Therapeutic Uses of H1 Antihistaminics,,True,1,2011-02,n=PH-kdtemp&ed=8&vol=0#178;n=PH-tarav&ed=4&vol=0#231,,
+S_PH_1.16.1.1.1.3,Therapeutic Uses of H1 Antihistamines,,True,1,2011-02,n=PH-kdtemp&ed=8&vol=0#178;n=PH-tarav&ed=4&vol=0#231,,
 S_PH_1.16.2.2.2,Drugs used in Prophylaxis of Migraine,,True,5,2022-03;2017-08;2011-08;2009-02;2000-04,n=PH-kdtemp&ed=8&vol=0#194;n=PH-tarav&ed=4&vol=0#237,,
 S_PH_1.16.4.2,Selective Cox-2 Inhibitors,,True,6,2018-02;2014-08;2011-08;2010-02;2009-08;2008-08,n=PH-kdtemp&ed=8&vol=0#221;n=PH-tarav&ed=4&vol=0#247,,
-S_PH_1.16.1.1.1.2,Second Generation Antihistaminics,- Non Sedative H1 Blockers;- Ebastine;- Azelastine;- Rupatadine,True,7,2020-02;2019-08;2014-08;2013-08;2008-08;2005-08;2004-08,n=PH-kdtemp&ed=8&vol=0#181;n=PH-tarav&ed=4&vol=0#232,,
+S_PH_1.16.1.1.1.2,Second Generation Antihistamines,- Non Sedative H1 Blockers;- Ebastine;- Azelastine;- Rupatadine,True,7,2020-02;2019-08;2014-08;2013-08;2008-08;2005-08;2004-08,n=PH-kdtemp&ed=8&vol=0#181;n=PH-tarav&ed=4&vol=0#232,,
 S_PH_1.16.4.1.1.1;1.16.4.1.1.2;1.16.4.1.1.3;1.16.4.1.1.4,Aspirin,- Contraindications;- Effects on Acid Base and Electrolyte Balance;- Dose Dependant Actions;- Uses,True,5,2023-07;2019-02;2016-02;2013-08;2011-02,n=PH-kdtemp&ed=8&vol=0#212;n=PH-tarav&ed=4&vol=0#241,,
 S_PH_1.16.6.1,Disease Modifying Anti-Rheumatic Drugs (DMARDs),,True,2,2022-08;2011-02,n=PH-kdtemp&ed=8&vol=0#227;n=PH-tarav&ed=4&vol=0#252,,
 S_PH_1.16.5.1,Acute Gout,,True,3,2023-02;2014-08;2012-02,n=PH-kdtemp&ed=8&vol=0#231;n=PH-tarav&ed=4&vol=0#249,,
-S_PH_1.16.1.1.1.1,First Generation Antihistaminics,,True,1,2013-08,n=PH-kdtemp&ed=8&vol=0#174;n=PH-tarav&ed=4&vol=0#231,,
+S_PH_1.16.1.1.1.1,First Generation Antihistamines,,True,1,2013-08,n=PH-kdtemp&ed=8&vol=0#174;n=PH-tarav&ed=4&vol=0#231,,
 S_PH_1.16.4.1.2.1,Acute Paracetamol Poisoning,,True,1,2014-08,n=PH-kdtemp&ed=8&vol=0#223;n=PH-tarav&ed=4&vol=0#248,,
-S_PH_1.16.1.1.1.1;1.16.1.1.1.2,Difference between 1st and 2nd Generation Antihistaminics,,True,1,2020-02,n=PH-kdtemp&ed=8&vol=0#179;n=PH-tarav&ed=4&vol=0#231,,
+S_PH_1.16.1.1.1.1;1.16.1.1.1.2,Difference between 1st and 2nd Generation Antihistamines,,True,1,2020-02,n=PH-kdtemp&ed=8&vol=0#179;n=PH-tarav&ed=4&vol=0#231,,
 S_PH_1.16.6.2,Role of Biologics in Rheumatoid Arthritis,,True,1,2020-11,n=PH-kdtemp&ed=8&vol=0#230;n=PH-tarav&ed=4&vol=0#254,,
 S_PH_1.16.2;1.16.2.1,Serotonin (5-HT) Antagonist,- Cyproheptadine,True,3,2013-08;2007-02;2005-02,n=PH-kdtemp&ed=8&vol=0#189;n=PH-tarav&ed=4&vol=0#234,,
 S_PH_1.16.4.3.1,Nimesulide,- Preferential COX-2 Inhibitor,True,2,2015-08;2012-08,n=PH-kdtemp&ed=8&vol=0#220;n=PH-tarav&ed=4&vol=0#245,,
diff --git a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Autonomic Nervous System.csv b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Autonomic Nervous System.csv
index a00a6ff..5dd3775 100644
--- a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Autonomic Nervous System.csv	
+++ b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Autonomic Nervous System.csv	
@@ -7,7 +7,7 @@ S_PH_1.13.3,Alpha Adrenergic Blockers,- Therapeutic Uses,True,4,2018-08;2016-08;
 S_PH_1.14.2,Anti-Glaucoma Drugs,,True,5,2018-08;2016-08;2013-08;2011-02;2009-02,n=PH-kdtemp&ed=8&vol=0#153,,
 S_PH_1.13.1,Labetalol,"- Uses 
 - Adverse Effects",True,1,2019-02,n=PH-kdtemp&ed=8&vol=0#165,,
-E_PH_1.14.1,Organo Phosphorous Compound poisoning,"- Antidote
+E_PH_1.14.1,Organo-phosphorus Compound poisoning,"- Antidote
 - Receptor antagonism with suitable diagrams
 - Cholinergic crisis in Myasthenia Gravis",True,1,2021-02,n=PH-kdtemp&ed=8&vol=0#122,,
 S_PH_1.13.4,Beta-Blockers,"- Therapeutic uses
@@ -51,6 +51,6 @@ E_PH_1.14.3,Atropine,"- Classification of Anti-Cholinergic drugs
 S_PH_1.13.10,Dopamine in Cardiogenic Shock,,True,2,2010-02;2009-08,n=PH-kdtemp&ed=8&vol=0#146,,
 E_PH_1.14.4,Anti-Cholinersterases,"- Mechanism of Action
 - Indication of Reversible Anti-Cholinersterases
-- Management of Acute Organophosphorous Poisoning",True,1,2013-08;2011-08,n=PH-kdtemp&ed=8&vol=0#116,,
+- Management of Acute Organophosphorus Poisoning",True,1,2013-08;2011-08,n=PH-kdtemp&ed=8&vol=0#116,,
 S_PH_1.13.11,Uroselective Alpha Adrenergic Blockers,,True,1,2012-08,n=PH-kdtemp&ed=8&vol=0#156,,
 S_PH_1.14.4,Cholinergic Crisis,,True,1,2014-08,n=PH-kdtemp&ed=8&vol=0#121,,
diff --git a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Cardiovascular System.csv b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Cardiovascular System.csv
index 95b1e6d..61a7fbe 100644
--- a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Cardiovascular System.csv	
+++ b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Cardiovascular System.csv	
@@ -54,8 +54,8 @@ S_PH_1.27.1.1,Beta Blockers as Anti-hypertensives,,True,1,2009-08,n=PH-kdtemp&ed
 S_PH_1.29.1,Cardiac Glycosides,,True,2,2019-08;2009-08,n=PH-kdtemp&ed=8&vol=0#556,,
 S_PH_1.24.1.4,Osmotic Diuretics,,True,5,2014-02;2012-02;2010-02;2008-02;2004-08,n=PH-kdtemp&ed=8&vol=0#637,,
 S_PH_1.27.1.1.1,Carvedilol,,True,1,2010-02,n=PH-kdtemp&ed=8&vol=0#610,,
-S_PH_1.25.3,Anti-platlet Drugs,,True,5,2023-07;2023-02;2017-08;2015-02;2010-02,n=PH-kdtemp&ed=8&vol=0#676,,
-S_PH_1.31.2.1,Atarvostatin,,True,2,2010-02;2008-02,n=PH-kdtemp&ed=8&vol=0#685,,
+S_PH_1.25.3,Anti-platelet Drugs,,True,5,2023-07;2023-02;2017-08;2015-02;2010-02,n=PH-kdtemp&ed=8&vol=0#676,,
+S_PH_1.31.2.1,Atorvastatin,,True,2,2010-02;2008-02,n=PH-kdtemp&ed=8&vol=0#685,,
 S_PH_1.24.1.2,Thiazide Diuretics,,True,6,2017-08;2017-02;2013-08;2011-08;2010-08;2003-10,n=PH-kdtemp&ed=8&vol=0#628,,
 S_PH_1.25.2.1,Heparin,- Heparin vs Warfarin;- Low Molecular Weight Heparin,True,10,2022-03;2020-11;2019-08;2015-02;2014-08;2013-08;2011-02;2010-08;2005-08;2004-08;2001-04;1998-04;1993-01,n=PH-kdtemp&ed=8&vol=0#663,,
 S_PH_1.28.3,Myocardial Infarction,,True,3,2014-02;2013-08;2010-08,n=PH-kdtemp&ed=8&vol=0#602,,
@@ -93,4 +93,4 @@ E_PH_1.28.3,Myocardial Infarction,"- Drug Therapy in Myocardial Infarction
 - Mechanism of Action of Statins
 - Uses of Statins
 - Adverse Effects of Statins",True,1,2023-07,n=PH-kdtemp&ed=8&vol=0#602,,
-S_PH_1.25.1.1.1,Parentral Iron Therapy,- Iron Preparations;- Uses,True,5,2023-02;2022-08;2019-08;2011-08;2004-08,n=PH-kdtemp&ed=8&vol=0#649,,
+S_PH_1.25.1.1.1,Parenteral Iron Therapy,- Iron Preparations;- Uses,True,5,2023-02;2022-08;2019-08;2011-08;2004-08,n=PH-kdtemp&ed=8&vol=0#649,,
diff --git a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Central Nervous System.csv b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Central Nervous System.csv
index a9379c4..48f65d2 100644
--- a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Central Nervous System.csv	
+++ b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Central Nervous System.csv	
@@ -27,7 +27,7 @@ E_PH_1.19.8,Opioids,"- Enumerate drugs acting on opioid receptors;- Mechanism of
 - Uses
 - Adverse Effects
 - Contraindications of Morphine;- Clinical Features of Acute Morphine Poisoning and Treatment;- Classification of Opioid analgesics;- Opioid Antagonists",True,4,2023-07;2007-02;2000-04;2000-04,n=PH-kdtemp&ed=8&vol=0#497,,
-E_PH_1.19.1,General Anasthetics,"- Classification
+E_PH_1.19.1,General Anaesthetics,"- Classification
 - Stages
 - Merits and demerits of Halothane and Ether as an anaesthetic",True,1,2004-08;2003-10,n=PH-kdtemp&ed=8&vol=0#400,,
 S_PH_1.19.7.3,Selective Serotonin Re-uptake Inhibitors (SSRIs),,True,6,2014-08;2013-02;2010-02;2008-08;2008-02;2005-08,n=PH-kdtemp&ed=8&vol=0#487,,
diff --git a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/General Pharmacology.csv b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/General Pharmacology.csv
index ba3b00b..d6c78bb 100644
--- a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/General Pharmacology.csv	
+++ b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/General Pharmacology.csv	
@@ -1,7 +1,7 @@
 Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations,ProbableCases,ReferenceLinks
 E_PH_1.4.1,Biotransformation,"- Biotransformation Reactions
 - Phase I and Phase II reaction with suitable examples
-- Importance of Enzyme Induction and Enzyme Inhibition;- Microsomal Enzyme Induction and Inhibition with examples",True,2,2014-08;2010-02,n=PH-kdtemp&ed=8&vol=0#28,"A 35 year old woman taking combined oral contraceptive pills. She was a diagnosed as a case of tuberculosis and put on isoniazid, rifampicin, pyrazinamide, and ethambutol combination therapy for 2 months followed by isoniazid and rifampicin thrice weekly for 4 months. In the 3rd month of treatement, she failed to have withdrawal bleeding during the gap period of contraceptive cycle. One week later her urinary pregnancy test was found to be positive.",
+- Importance of Enzyme Induction and Enzyme Inhibition;- Microsomal Enzyme Induction and Inhibition with examples",True,2,2014-08;2010-02,n=PH-kdtemp&ed=8&vol=0#28,"A 35 year old woman taking combined oral contraceptive pills. She was a diagnosed as a case of tuberculosis and put on isoniazid, rifampicin, pyrazinamide, and ethambutol combination therapy for 2 months followed by isoniazid and rifampicin thrice weekly for 4 months. In the 3rd month of treatment, she failed to have withdrawal bleeding during the gap period of contraceptive cycle. One week later her urinary pregnancy test was found to be positive.",
 S_PH_1.1.1,Pharmacogenetics,- Two Examples,True,6,2023-02;2021-09;2017-08;2009-02;2008-02;2001-04,n=PH-kdtemp&ed=8&vol=0#75,,
 S_PH_1.11.2.1,Sublingual Route of Drug Administration,,True,3,2011-08;2008-08;1997-10,n=PH-kdtemp&ed=8&vol=0#12,,
 E_PH_1.11,Routes of Drug Administration,"- Explanation of Each Route
@@ -28,7 +28,7 @@ S_PH_1.4.6,Blood Brain Barrier,,True,1,2011-08,n=PH-kdtemp&ed=8&vol=0#24,,
 S_PH_1.1.2,Essential Drugs,,True,1,2012-02,n=PH-kdtemp&ed=8&vol=0#6,,
 S_PH_1.4.1.2,Microsomal Enzyme Inducers,,True,2,2023-02;2012-02,n=PH-kdtemp&ed=8&vol=0#33,,
 S_PH_1.59.1,Fixed Dose Ratio Combination,,True,1,2013-02,n=PH-kdtemp&ed=8&vol=0#72,,
-S_PH_1.4.7,Specialized Active Transport Mechanism Across Blological Membrane,,True,1,2013-08,n=PH-kdtemp&ed=8&vol=0#18,,
+S_PH_1.4.7,Specialized Active Transport Mechanism Across Biological Membrane,,True,1,2013-08,n=PH-kdtemp&ed=8&vol=0#18,,
 S_PH_1.6.1,Pharmacovigilance,,True,6,2022-08;2022-03;2021-09;2018-02;2016-02;2013-08,n=PH-kdtemp&ed=8&vol=0#93,,
 S_PH_1.11.2.3,Parenteral Route of Drug Administration,,True,1,2019-08,n=PH-kdtemp&ed=8&vol=0#13,,
 S_PH_1.7.2,Drugs in Anaphylactic Shock,,True,1,,n=PH-kdtemp&ed=8&vol=0#97,,
@@ -47,6 +47,6 @@ S_PH_1.5.3,Drug Synergism,,True,1,2016-02,n=PH-kdtemp&ed=8&vol=0#66,,
 S_PH_1.11.2.4,Rectal Route of Administration,- Merits and Demerits,True,1,2023-12,n=PH-kdtemp&ed=8&vol=0#12,,
 S_PH_1.1.3,Orphan Drugs,,True,1,2018-08,n=PH-kdtemp&ed=8&vol=0#7,,
 S_PH_1.64.2,Phase III Clinical Trial,,True,2,2022-02;2019-02,n=PH-kdtemp&ed=8&vol=0#91,,
-S_PH_1.4.8,Zero Order Pharmacokinectics,,True,1,2019-08,n=PH-kdtemp&ed=8&vol=0#38,,
+S_PH_1.4.8,Zero Order Pharmacokinetics,,True,1,2019-08,n=PH-kdtemp&ed=8&vol=0#38,,
 S_PH_1.5.4.2,Physical Antagonism,,True,1,2020-11,n=PH-kdtemp&ed=8&vol=0#67,,
 S_PH_1.6.2,Causality Assessment,,True,1,2022-08,n=PH-kdtemp&ed=8&vol=0#93,,
diff --git a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Respiratory System.csv b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Respiratory System.csv
index 6e4457d..69a50aa 100644
--- a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Respiratory System.csv	
+++ b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 1/Respiratory System.csv	
@@ -36,8 +36,8 @@ S_PH_1.33.1,Centrally Acting Cough Syrup,"- Classification
 - Mechanism of action
 - Uses
 - Adverse Effects",True,1,2001-11,n=PH-kdtemp&ed=8&vol=0#239,,
-S_PH_1.32.4,Zilueton,,True,1,2005-08,n=PH-kdtemp&ed=8&vol=0#249,,
-S_PH_1.32.1;1.32.5;1.32.7,Bronchodilators,"- Classification: Sympathomimmetics, Methyl xanthines, Anticholinergics
+S_PH_1.32.4,Zileuton,,True,1,2005-08,n=PH-kdtemp&ed=8&vol=0#249,,
+S_PH_1.32.1;1.32.5;1.32.7,Bronchodilators,"- Classification: Sympathomimetics, Methyl xanthines, Anticholinergics
 - Mechanism of action
 - Uses
 - Adverse Effects",True,1,2007-08,n=PH-kdtemp&ed=8&vol=0#242,,
diff --git a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Anti-Microbial Drugs.csv b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Anti-Microbial Drugs.csv
index fdd3a8d..dac3181 100644
--- a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Anti-Microbial Drugs.csv	
+++ b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Anti-Microbial Drugs.csv	
@@ -2,7 +2,7 @@ Id,Title,Descriptions,HasPreviouslyBeenAsked,Importance,YearsAsked,BookLocations
 S_PH_1.47.3.1,Metronidazole,,True,9,2022-08;2021-09;2011-02;2010-08;2003-10;2000-04;1998-04;1996-10;1994-11,n=PH-kdtemp&ed=8&vol=0#894,,
 S_PH_1.42.9.2,Clarithromycin,,True,2,2011-02;2009-02,n=PH-kdtemp&ed=8&vol=0#803,,
 S_PH_1.48.4,Anti Retroviral Drugs,,True,4,2008-08;2006-02;2002-03;2000-10,n=PH-kdtemp&ed=8&vol=0#860,,
-S_PH_1.42.3,Flouroquinolones,,True,2,2008-08;1994-11,n=PH-kdtemp&ed=8&vol=2#760,,
+S_PH_1.42.3,Fluoroquinolones,,True,2,2008-08;1994-11,n=PH-kdtemp&ed=8&vol=2#760,,
 S_PH_1.47.1.6,Primaquine,,True,2,2010-08;2009-02,n=PH-kdtemp&ed=8&vol=0#885,,
 S_PH_1.44.2,Rifampicin,,True,4,2023-12;2009-02;1998-10;1991-12,n=PH-kdtemp&ed=8&vol=0#818,,
 S_PH_1.42.2.4.3,3rd Generation Cephalosporins,,True,7,2023-12;2020-11;2009-08;2008-02;2005-08;2000-10;1999-04,n=PH-kdtemp&ed=8&vol=0#777,,
@@ -13,7 +13,7 @@ S_PH_1.42.2.1,Repository Preparations of Penicillin,,True,1,2009-08,n=PH-kdtemp&
 S_PH_1.42.8.2,Amikacin,,True,1,2010-02,n=PH-kdtemp&ed=8&vol=0#799,,
 S_PH_1.42.7,Doxycycline,,True,1,2010-02,n=PH-kdtemp&ed=8&vol=0#787,,
 S_PH_1.47.1.2,Chloroquine,,True,4,2023-02;2010-02;2008-02;2004-08,n=PH-kdtemp&ed=8&vol=0#879,,
-S_PH_1.42.14.2,Fluconazole,- Uses;- Advantage over ketaconazole,True,1,2010-02,n=PH-kdtemp&ed=8&vol=0#844,,
+S_PH_1.42.14.2,Fluconazole,- Uses;- Advantage over ketoconazole,True,1,2010-02,n=PH-kdtemp&ed=8&vol=0#844,,
 S_PH_1.47.1.12,Management of Cerebral Malaria,,True,1,2010-08,n=PH-kdtemp&ed=8&vol=0#883,,
 S_PH_1.47.9,Ivermectin,,True,2,2023-07;2011-02,n=PH-kdtemp&ed=8&vol=0#911,,
 S_PH_1.43.1,Bacterial Drug Resistance,,True,4,2011-02;2010-02;2006-02;2003-10,n=PH-kdtemp&ed=8&vol=0#742,,
@@ -22,7 +22,7 @@ S_PH_1.43.4,Drugs in Typhoid fever,,True,1,2011-08,n=PH-kdtemp&ed=8&vol=0#762,,
 S_PH_1.47.8,Diethylcarbamazine Citrate (DEC),,True,1,2011-08,n=PH-kdtemp&ed=8&vol=0#910,,
 S_PH_1.42.9.2,Newer Macrolides,,True,1,2013-02,n=PH-kdtemp&ed=8&vol=0#803,,
 S_PH_1.47.1.2,Artemisinin Combination Therapy,"- Advantages
-- Pharmacological Basis of Artemesinin Aerivatives in Malaria",True,3,2015-08;2014-02;2005-08,n=PH-kdtemp&ed=8&vol=0#889,,
+- Pharmacological Basis of Artemisinin Derivatives in Malaria",True,3,2015-08;2014-02;2005-08,n=PH-kdtemp&ed=8&vol=0#889,,
 S_PH_1.44.9,Role of Corticosteroids in Management of Tuberculosis,,True,1,2013-08,n=PH-kdtemp&ed=8&vol=0#828,,
 S_PH_1.47.6,Albendazole,,True,6,2014-02;2013-08;2005-08;2005-02;2003-10;2000-10,n=PH-kdtemp&ed=8&vol=0#908,,
 S_PH_1.42.2.4.4,4th generation Cephalosporins,,True,1,2014-02,n=PH-kdtemp&ed=8&vol=0#779,,
@@ -33,10 +33,10 @@ S_PH_1.42.4,Cotrimoxazole,"- Rationale in Use;- Mechanism of Action
 S_PH_1.42.17,Terbinafine,,True,1,2018-02,n=PH-kdtemp&ed=8&vol=0#847,,
 S_PH_1.46.1,Dapsone,- Sulfone syndrome,True,3,2018-08;2014-08;2008-02,n=PH-kdtemp&ed=8&vol=0#831,,
 S_PH_1.48.5,Principles and Guidelines in Treatment of HIV,,True,1,2018-08,n=PH-kdtemp&ed=8&vol=0#867,,
-S_PH_1.48.4.1,Nucleoside Revere Transcriptase Inhibitors,,True,3,2019-02;2007-02;1997-04,n=PH-kdtemp&ed=8&vol=0#861,,
+S_PH_1.48.4.1,Nucleoside Reverse Transcriptase Inhibitors,,True,3,2019-02;2007-02;1997-04,n=PH-kdtemp&ed=8&vol=0#861,,
 S_PH_1.48.5.3,Highly Active Anti-Retroviral Therapy (HAART),,True,2,2022-08;2019-08,n=PH-kdtemp&ed=8&vol=0#868,,
 S_PH_1.48.1.1,Acyclovir,,True,2,2023-02;2019-08,n=PH-kdtemp&ed=8&vol=0#850,,
-S_PH_1.46.2,Clofazamine,- Rationale in Lepra Reaction,True,2,2012-08;2010-08,n=PH-kdtemp&ed=8&vol=0#832,,
+S_PH_1.46.2,Clofazimine,- Rationale in Lepra Reaction,True,2,2012-08;2010-08,n=PH-kdtemp&ed=8&vol=0#832,,
 S_PH_1.42.15,Anti-Pseudomonal Penicillins (or) Piperacillin,,True,1,2014-08,n=PH-kdtemp&ed=8&vol=0#774,,
 S_PH_1.48.4.3,Retroviral Protease Inhibitors and Combination Therapy,,True,1,2021-09,n=PH-kdtemp&ed=8&vol=0#864,,
 S_PH_1.42.13.1,Amphotericin B,- Therapeutic Uses;- New Formulations,True,5,2023-07;2022-03;2022-02;2014-08;1993-11,n=PH-kdtemp&ed=8&vol=0#839,,
@@ -47,7 +47,7 @@ S_PH_1.42.3.1,Ciprofloxacin,"- Mechanism of Action
 - Uses;- Why Ciprofloxacin is Contraindicated in Children less than 8 years of age",True,2,2022-03;2004-08,n=PH-kdtemp&ed=8&vol=0#760,,
 S_PH_1.42.11,Vancomycin,,True,3,2023-07;2022-08;2013-08,n=PH-kdtemp&ed=8&vol=0#806,,
 S_PH_1.48.5.2,Post-Exposure Prophylaxis (PEP) of HIV infection,,True,2,2023-07;2014-08,n=PH-kdtemp&ed=8&vol=0#871,,
-S_PH_1.42.14.1,Ketaconazole,,True,1,2010-08,n=PH-kdtemp&ed=8&vol=0#844,,
+S_PH_1.42.14.1,Ketoconazole,,True,1,2010-08,n=PH-kdtemp&ed=8&vol=0#844,,
 S_PH_1.42.8,Aminoglycosides,"- Mechanism of Action
 - Adverse Drug Reactions",True,5,2022-03;2018-02;2015-08;2008-08;2006-08,n=PH-kdtemp&ed=8&vol=0#793,,
 S_PH_1.44.6,Short Course Chemotherapy in Treatment of Tuberculosis,,True,5,2020-02;2019-02;2014-08;1996-10;1996-04,n=PH-kdtemp&ed=8&vol=0#824,,
@@ -59,7 +59,7 @@ S_PH_1.42.8.1,Gentamicin,,True,3,2012-08;2005-02;2001-11,n=PH-kdtemp&ed=8&vol=0#
 S_PH_1.48.4.4,Fusion Inhibitors in HIV infections,,True,1,2012-08,n=PH-kdtemp&ed=8&vol=0#867,,
 S_PH_1.47.1.3,Mefloquine,,True,2,2002-03;2000-10,n=PH-kdtemp&ed=8&vol=0#881,,
 S_PH_1.47.10,Praziquantel,,True,2,2006-08;2001-04,n=PH-kdtemp&ed=8&vol=0#912,,
-S_PH_1.47.7,Pyrantel Pamonate,,True,1,2001-11,n=PH-kdtemp&ed=8&vol=0#909,,
+S_PH_1.47.7,Pyrantel Pamoate,,True,1,2001-11,n=PH-kdtemp&ed=8&vol=0#909,,
 S_PH_1.42.2.3,Semisynthetic Penicillins,,True,2,2013-02;2005-02,n=PH-kdtemp&ed=8&vol=0#770,,
 S_PH_1.47.1.9,Management of Chloroquine Resistant Malaria,,True,1,2006-02,n=PH-kdtemp&ed=8&vol=0#877,,
 S_PH_1.42.5,Broad Spectrum Penicillins,,True,1,2006-08,n=PH-kdtemp&ed=8&vol=0#772,,
@@ -119,13 +119,13 @@ E_PH_1.44,Anti-tubercular drugs (or) Treatment of Tuberculosis,"- Classification
 - Adverse Drug Reactions of Any 1 Drug;- Treatment of Pulmonary TB
 - Bacterial Resistance;- Mechanism of Action
 - Adverse Drug Reactions of Any 2 Drugs",True,5,2023-07;2016-08;2011-02;2010-02;2008-02,n=PH-kdtemp&ed=8&vol=0#816,"A 25 year old male came with complaints of **cough with expectoration, evening rise of temperature, sweating and loss of appetite** for past 2 weeks",
-E_PH_1.42.3,Flouroquinolones,"- Classification
+E_PH_1.42.3,Fluoroquinolones,"- Classification
 - Mechanism of Action
 - Uses
-- 2nd Generation Flouroquinolones",True,3,2013-02;1996-10;1994-11,n=PH-kdtemp&ed=8&vol=0#760,,
+- 2nd Generation Fluoroquinolones",True,3,2013-02;1996-10;1994-11,n=PH-kdtemp&ed=8&vol=0#760,,
 E_PH_1.42.14,Anti-Fungal agents,"- Classification
 - Imidazoles: Mechanism of Action
-- Ketaconazole: Uses and Adverse Drug Reactions;- Classification
+- Ketoconazole: Uses and Adverse Drug Reactions;- Classification
 - Fluconazole
 - Mechanism of Action
 - Adverse Drug Reactions
@@ -174,7 +174,7 @@ E_PH_1.43.4,Drugs for Treatment of Typhoid,"- Ciprofloxacin
 - Adverse Drug Reactions
 - Uses
 - Treatment of Ciprofloxacin Resistant Cases",True,1,2023-02,n=PH-kdtemp&ed=8&vol=0#762,"A 15 year old girl admitted with complaints of high fever, head ache and stomach pain. She revealed that she had visited marina beach last week end and ate from roadside food stall",
-S_PH_1.47.5,Mebendzole,"- Indications;- Mechanism of Action
+S_PH_1.47.5,Mebendazole,"- Indications;- Mechanism of Action
 - Adverse Drug Reactions",True,3,2015-02;2009-08;1997-10,n=PH-kdtemp&ed=8&vol=0#906,,
 S_PH_1.42.9.3,Azithromycin,"- Antibacterial Spectrum
 - Mechanism of Action
@@ -182,6 +182,6 @@ S_PH_1.42.9.3,Azithromycin,"- Antibacterial Spectrum
 - Uses",True,2,2017-08;2012-08,n=PH-kdtemp&ed=8&vol=0#804,,
 S_PH_1.47.1.4,Quinine,,True,1,2009-02,n=PH-kdtemp&ed=8&vol=0#882,,
 S_PH_1.42.1.1,Topical Sulphonamides,,True,1,2009-08,n=PH-kdtemp&ed=8&vol=0#756,,
-S_PH_1.42.2.5.2,Imepenem,,True,2,2015-02;2013-02,n=PH-kdtemp&ed=8&vol=0#782,,
+S_PH_1.42.2.5.2,Imipenem,,True,2,2015-02;2013-02,n=PH-kdtemp&ed=8&vol=0#782,,
 S_PH_1.42.2.4,Cephalosporins,,True,1,1990-12,n=PH-kdtemp&ed=8&vol=0#775,,
 S_PH_1.42.2.3.2,Therapeutic Uses of Amoxycillin,,True,1,1998-04,n=PH-kdtemp&ed=8&vol=0#773,,
diff --git a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Gastrointestinal System.csv b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Gastrointestinal System.csv
index f5082b5..2739fc2 100644
--- a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Gastrointestinal System.csv	
+++ b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Gastrointestinal System.csv	
@@ -20,7 +20,7 @@ S_PH_1.34.3,Drugs for H. pylori Infection,- Triple Regimen,True,5,2023-07;2017-0
 S_PH_1.34.3,Anti-Emetic Drugs,- Morning Sickness,True,2,2018-08;2008-02,n=PH-kdtemp&ed=8&vol=0#710,,
 S_PH_1.34.1.2,H2 Receptor Antagonists,,True,5,2023-02;2002-03;2000-10;1996-10;1993-01,n=PH-kdtemp&ed=8&vol=0#696,,
 S_PH_1.34.1.2,Ranitidine,,True,3,2018-02;2011-08;1996-10,n=PH-kdtemp&ed=8&vol=0#698,,
-S_PH_1.34.3.1,Metaclopramide,,True,3,2023-07;2019-02;1997-04,n=PH-kdtemp&ed=8&vol=0#713,,
+S_PH_1.34.3.1,Metoclopramide,,True,3,2023-07;2019-02;1997-04,n=PH-kdtemp&ed=8&vol=0#713,,
 S_PH_1.34.1.2,Prostaglandin Analogues in Peptic Ulcer Disease,,True,1,2020-02,n=PH-kdtemp&ed=8&vol=0#702,,
 S_PH_1.34.1.3,Sucralfate,,True,2,2009-08;1999-04,n=PH-kdtemp&ed=8&vol=0#704,,
 S_PH_1.34.5.2,Sulfasalazine,,True,2,2014-08;2013-08,n=PH-kdtemp&ed=8&vol=0#734,,
diff --git a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Hormones.csv b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Hormones.csv
index 93df9f6..ece8d07 100644
--- a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Hormones.csv	
+++ b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Hormones.csv	
@@ -12,7 +12,7 @@ E_PH_1.39.1,Oral Contraceptives,"- Classification of Anti Fertility Drugs
 E_PH_1.38.1.1,Corticosteroids,"- Classification of Glucocorticoids
 - Physiological and Pharmacological Actions
 - Adverse Effects
-- Therapautic Uses
+- Therapeutic Uses
 - Contraindications;- Note on Acute Adrenal Insufficiency",True,3,2006-08;2005-08;2001-04,n=PH-kdtemp&ed=8&vol=0#306;n=PH-tarav&ed=5&vol=0#346,,
 S_PH_1.36.2.1,Propylthiouracil,,True,3,2018-02;2011-08;2004-08,n=PH-kdtemp&ed=8&vol=0#275;n=PH-tarav&ed=5&vol=0#325,,
 S_PH_1.39.1,Adverse Effects of Hormonal Contraceptives,,True,1,2004-08,n=PH-kdtemp&ed=8&vol=0#350;n=PH-tarav&ed=5&vol=0#343,,
diff --git a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Miscellaneous Drugs.csv b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Miscellaneous Drugs.csv
index bb1b55f..0e75445 100644
--- a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Miscellaneous Drugs.csv	
+++ b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Miscellaneous Drugs.csv	
@@ -6,7 +6,7 @@ S_PH_1.53.1,Chelating Agents,,True,3,2023-02;2022-08;2007-02,n=PH-kdtemp&ed=8&vo
 S_PH_1.57.4,Keratolytic Agents,,True,1,2023-02,n=PH-kdtemp&ed=8&vol=0#949,,
 S_PH_1.50.2.1,Mycophenolate Mofetil,,True,4,2023-07;2020-11;2012-08;2007-08,n=PH-kdtemp&ed=8&vol=0#942,,
 S_PH_1.61.1,Vitamin A,,True,2,2013-02;2002-03,n=PH-kdtemp&ed=8&vol=0#968,,
-S_PH_1.53.1.2,d-Pencillamine,,True,3,2009-08;2004-08;2000-04,n=PH-kdtemp&ed=8&vol=0#966,,
+S_PH_1.53.1.2,d-Penicillamine,,True,3,2009-08;2004-08;2000-04,n=PH-kdtemp&ed=8&vol=0#966,,
 S_PH_1.50,Immunosuppressants,,True,4,2008-08;2002-03;2000-10;2000-04,n=PH-kdtemp&ed=8&vol=0#937,,
 S_PH_1.53.1.1,Dimercaprol (or) British Anti-Lewisite (BAL),,True,8,2015-02;2013-02;2011-02;2010-08;2008-08;2005-02;2004-08;2001-04,n=PH-kdtemp&ed=8&vol=0#964,,
 S_PH_1.57.3,Scabies,,True,6,2017-08;2016-02;2010-08;2009-02;2004-08;2001-11,n=PH-kdtemp&ed=8&vol=0#961,,
@@ -16,8 +16,8 @@ S_PH_1.57.6,Sun Screens,,True,1,2005-08,n=PH-kdtemp&ed=8&vol=0#952,,
 S_PH_1.50.1.2,Tacrolimus,,True,1,2006-08,n=PH-kdtemp&ed=8&vol=0#940,,
 S_PH_1.53.1.3,Desferrioxamine,,True,2,2020-02;2009-02,n=PH-kdtemp&ed=8&vol=0#966,,
 S_PH_1.53.2,Therapeutic Uses of Oxygen,,True,1,2011-02,n=PH-ggpbint&ed=13&vol=0#399,,
-S_PH_1.50.1,Calcineurin Inhibitior,,True,3,2019-02;2013-08;2011-08,n=PH-kdtemp&ed=8&vol=0#937,,
-S_PH_1.57.5,Anti Seborrheics agents,,False,1,,n=PH-kdtemp&ed=8&vol=0#949,,
+S_PH_1.50.1,Calcineurin Inhibitors,,True,3,2019-02;2013-08;2011-08,n=PH-kdtemp&ed=8&vol=0#937,,
+S_PH_1.57.5,Anti-Seborrheic Agents,,False,1,,n=PH-kdtemp&ed=8&vol=0#949,,
 S_PH_1.54.2,Rabies Prophylaxis,,True,1,2003-02,n=PH-kdtemp&ed=8&vol=0#981,,
 S_PH_1.57.1.1,Psoralen Ultraviolet A (PUVA),,True,1,2013-08,n=PH-kdtemp&ed=8&vol=0#951,,
 S_PH_1.61.3,Vitamin K,,True,1,2016-08,n=PH-kdtemp&ed=8&vol=0#660,,
diff --git a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Neoplastic Drugs.csv b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Neoplastic Drugs.csv
index b8d22ba..6aa3621 100644
--- a/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Neoplastic Drugs.csv	
+++ b/src/Symptum.Data/Subjects/Pharmacology/Question Bank/Paper 2/Neoplastic Drugs.csv	
@@ -13,7 +13,7 @@ S_PH_1.49.3.1,Cisplatin,,True,4,2022-03;2011-08;2010-08;1995-11,n=PH-kdtemp&ed=8
 S_PH_1.49.5.1,Vincristine,,True,2,2023-02;2000-10,n=PH-kdtemp&ed=8&vol=0#924,,
 S_PH_1.49.2,"Alkylating Agents ","- Types
 - Therapeutic Uses",True,1,2008-08,n=PH-kdtemp&ed=8&vol=0#918,,
-S_PH_1.49.8,L-Asparginase,,True,1,2009-08,n=PH-kdtemp&ed=8&vol=0#928,,
+S_PH_1.49.8,L-Asparaginase,,True,1,2009-08,n=PH-kdtemp&ed=8&vol=0#928,,
 S_PH_1.49.4.1.1,Folinic Acid,- Citrovorum Factor Rescue;- Leucovorin Rescue,True,2,2014-08;2010-02,n=PH-kdtemp&ed=8&vol=0#921,,
 E_PH_1.49.1;1.49.4,"Classification of Anti-Cancer Drugs, Anti-Metabolites","- Name Antimetabolites
 - Mechanism of Action of Methotrexate